Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Receptor Sensitivity and the Mechanism of Action of Antidepressant Treatment: Implications for the Etiology and Therapy of Depression

Receptor Sensitivity and the Mechanism of Action of Antidepressant Treatment: Implications for... Abstract • Considerable evidence suggests that the acute effects of antidepressant treatments on brain norepinephrine (NE) and serotonin (5-HT) systems cannot account fully for their delayed therapeutic action. This review evaluates the effects of long-term antidepressant treatment on biogenic amine metabolism and on various indexes of presynaptic and postsynaptic receptor function. In contrast to variable effects on NE and 5-HT turnover and on presynaptic receptor sensitivity, almost all long-term antidepressant treatments produce consistent alterations in a number of measures of postsynaptic amine receptor sensitivity. Longterm treatment has been found to reduce β-adrenergic sensitivity while enhancing responses to serotonergic and α-adrenergic stimulation, suggesting that modulation of receptor sensitivity may be a mechanism of action common to tricyclic antidepressants, "atypical" antidepressants, monoamine oxidase inhibitors, and electroconvulsive therapy. These findings provide support for hypotheses of amine receptor abnormalities in depression and indicate the need for expanded studies of amine receptor function in patients. References 1. References 31, 40, 66, 67, 69, 70, 72-74. 2. References 127-130, 136, 137, 142, 145, 154, 164-166. 3. References 167-175, 177, 178, 180, 181, 185, 187-189, 191, 195-204. 4. References 186, 209, 210, 213-215, 218-228. 5. Schildkraut JJ: The catecholamine hypothesis of affective disorders: A review of supporting evidence . Am J Psychiatry 1965;122:509-522. 6. Bunney WE Jr, Davis JM: Norepinephrine in depressive reactions: A review . Arch Gen Psychiatry 1965;13:483-494.Crossref 7. Maas JW: Biogenic amines and depression: Biochemical and pharmacological separation of two types of depression . Arch Gen Psychiatry 1975;32:1357-1361.Crossref 8. Sulser F, Vetulani J, Mobley PL: Mode of action of antidepressant drugs . Biochem Pharmacol 1978;27:257-261.Crossref 9. Rosloff BN, Davis JM: Effect of iprindole on norepinephrine turnover and transport . Psychopharmacologia 1974;40:53-64.Crossref 10. Gluckman MI, Baum T: The pharmacology of iprindole, a new antidepressant . Psychopharmacologia 1969;15:169-185. 11. Leonard BE: Some effects of a new tetracyclic antidepressant compound, Org GB94, on the metabolism of monoamines in the rat brain . Psychopharmacology 1974;36:221-236.Crossref 12. Goodlet F, Mireylees SE, Sugrue MF: Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines . Br J Pharmacol 1977;61:307-313.Crossref 13. Post RM, Kopin J, Goodwin FK: The effects of cocaine on depressed patients . Am J Psychiatry 1974;131:511-517. 14. Overall JE, Hollister LE, Pokorny AD, et al: Drug therapy in depressions: Controlled evaluation of imipramine, isocarboxazid, dextroamphetamine, amobarbital, and placebo . Clin Pharmacol Ther 1962;3:16-22. 15. Ghose K, Gupta R, Coppen A, et al: Antidepressant evaluation and the pharmacological actions of FG-4963 in depressive patients . Eur J Pharmacol 1977;42:31-37.Crossref 16. Iversen LL, Mackay AVP: Pharmacodynamics of antidepressants and antimanic drugs , in Paykel ES, Coppen A (eds): Psychopharmacology of Affective Disorders . New York, Oxford University Press Inc, 1979, pp 60-90. 17. Oswald I, Brezinova V, Dunleavy DLF: On the slowness of action of tricyclic antidepressant drugs . Br J Psychiatry 1972;120:673-677.Crossref 18. Klein DV, Gittelman R, Quitkin F, et al: Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children , ed 2. Baltimore, Williams & Wilkins Co, 1980. 19. Sugrue MF: Chronic antidepressant administration and adaptive changes in central monoaminergic systems , in Enna SJ, Malick JB, Richelson E (eds): Antidepressants: Neurochemical, Behavioral, and Clinical Perspectives . New York, Raven Press, to be published. 20. Roffman M, Kling MA, Cassens G, et al: The effects of acute and chronic administration of tricyclic antidepressants on MHPG-SO, in rat brain . Psychopharmacol Commun 1977;1:195-206. 21. Bareggi SR, Markey K, Genovese E: Effects of single and multiple doses of desipramine (DMI) on endogenous levels of 3-methoxy-4-hydroxyphenylglycol-sulfate (MOPEG-SO4) in rat brain . Eur J Pharmacol 1978;50:301-306.Crossref 22. Carlsson A, Lindqvist M: Effects of antidepressant agents on the synthesis of brain monoamines . J Neural Transm 1978;43:73-91.Crossref 23. Nielsen M: The influence of desipramine and amitriptyline on the accumulation of 3H-noradrenaline and its two major metabolites formed from 3H-tyrosine in the rat brain . J Pharm Pharmacol 1975;27:206-208.Crossref 24. Nielsen M, Braestrup C: Desipramine and some other antidepressant drugs decrease the major norepinephrine metabolite 3,4-dihydroxyphenylglycolsulphate in the rat brain . Naunyn Schmiedebergs Arch Pharmacol 1977;300:93-99.Crossref 25. Schildkraut JJ, Roffman M, Orsulak PJ, et al: Effects of short- and long-term administration of tricyclic antidepressants and lithium on norepinephrine turnover in brain . Pharmakopsychiatr Neuropsychopharmakol 1976;9:193-202.Crossref 26. Tang SW, Helmeste DM, Stancer HC: The effect of acute and chronic desipramine and amitriptyline treatment on rat brain total 3-methoxy4-hydroxyphenylglycol . Naunyn Schmiedebergs Arch Pharmacol 1978; 305:207-211.Crossref 27. Nielsen M, Eplov L, Scheel-Kruger J: The effect of amitriptyline, desipramine and imipramine on the in vivo brain synthesis of 3H-noradrenaline from 3H-l-dopa in the rat . Psychopharmacologia 1975;41:249-254.Crossref 28. Nyback HV, Walters JR, Aghajanian GK, et al: Tricyclic antidepressants: Effects on the firing rate of brain noradrenergic neurons . Eur J Pharmacol 1975;32:302-312.Crossref 29. Scuvee-Moreau JJ, Dresse AE: Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphe neurons of the rat . Eur J Pharmacol 1979;57:219-225.Crossref 30. Langer SZ, Briley MS, Raisman R: Regulation of neurotransmission through presynaptic receptors and other mechanisms: Possible clinical relevance and therapeutic potential , in Pepau G, Kuhar MJ, Enna SJ (eds): Receptors for Neurotransmitters and Peptides . New York, Raven Press, 1980, pp 203-206. 31. Cedarbaum JM, Aghajanian GK: Catecholamine receptors on locus coeruleus neurons: Pharmacological characterization . Eur J Pharmacol 1977;44:375-385.Crossref 32. Neff NM, Costa E: Effect of tricyclic antidepressants and chlorpromazine on brain catecholamine synthesis , in Garattini S, Dukes MNG (eds): Antidepressant Drugs . Amsterdam, Excerpta Medica, 1967, pp 28-34. 33. Pugsley TA, Lippmann W: Effect of acute and chronic treatment of tandamine, a new heterocyclic antidepressant, on biogenic amine metabolism and related activities . Naunyn Schmiedebergs Arch Pharmacol 1979;308:239-247.Crossref 34. Tang SW, Helmeste DM, Stancer HC: Interaction of antidepressants with clonidine on rat brain total 3-methoxy-4-hydroxyphenylglycol . Can J Physiol Pharmacol 1979;57:435-437.Crossref 35. Sugrue MF: Changes in rat brain monoamine turnover following chronic antidepressant administration . Life Sci 1980;26:423-429.Crossref 36. McMillen BA, Warnack W, German DC, et al: Effects of chronic desipramine treatment on rat brain noradrenergic responses to α-adrenergic drugs . Eur J Pharmacol 1980;61:239-246.Crossref 37. Segal DS, Kuczenski R, Mandell AJ: Theoretical implications of drug-induced adaptive regulation for a biogenic amine hypothesis of affective disorder . Biol Psychiatry 1974;9:147-159. 38. Nielsen M, Braestrup C: Chronic treatment with desipramine caused a sustained decrease of 3,4-dihydroxyphenylglycolsulphate and total 3-methoxy-4-hydroxyphenylglycol in the rat brain . Naunyn Schmiedebergs Arch Pharmacol 1977;300:87-92.Crossref 39. Rosloff BN, Davis JM: Decrease in brain NE turnover after chronic DMI treatment: No effect with iprindole . Psychopharmacology 1978;56:335-341.Crossref 40. Crews FT, Smith CB: Presynaptic alpha-receptor subsensitivity after long-term antidepressant treatment . Science 1978;202:322-324.Crossref 41. Harper B, Hughes IE: Presynaptic α-adrenoceptor blocking properties among tri- and tetra-cyclic antidepressant drugs . Br J Pharmacol 1979;67:511-517.Crossref 42. Huang YH, Maas JW, Hu G: The time course of noradrenergic preand post-synaptic activity during chronic desipramine treatment . Eur J Pharmacol 1980;68:41-47.Crossref 43. Schildkraut JJ, Winokur A, Draskoczy PR, et al: Changes in norepinephrine turnover in rat brain during chronic administration of imipramine and protriptyline: A possible explanation for the delay in onset of clinical antidepressant effects . Am J Psychiatry 1971;127:72-79. 44. Friedman E, Shopsin B, Goldstein M, et al: Interactions of imipramine and synthesis inhibitors of biogenic amines . J Pharm Pharmacol 1974;26:995-997.Crossref 45. Mogilnicka E, Klimek V: Effect of chronic administration of antidepressant drugs on the noradrenaline disappearance induced by FLA-63 in the rat brain . Pol J Pharmacol Pharm 1979;31:139-147. 46. Schildkraut JJ, Winokur A, Applegate CW: Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine . Science 1970;168:867-869.Crossref 47. Svensson TH, Usdin T: Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: α-Receptor mediation . Science 1978;202:1089-1091.Crossref 48. Svensson TH: Effect of chronic treatment with tricyclic antidepressant drugs on identified brain noradrenergic and serotonergic neurons . Acta Psychiatr Scand 1980;61( (suppl 280) ):121-131. 49. Brogden RN, Heel RC, Speight TM: Mianserin: A review of its pharmacological properties and therapeutic efficacy in depressive illness . Drugs 1978;16:273-301.Crossref 50. Peet M, Bahagel H: Mianserin: A decade of scientific development . Br J Pharmacol 1978;5:5S-9S. 51. Leonard BE: Some effects of mianserin on monoamine metabolism in the rat brain . Br J Pharmacol 1978;5:11S-12S. 52. Coppen A, Ghose K, Swade C, et al: Effect of mianserin hydrochloride on peripheral uptake mechanisms for noradrenaline and 5-hydroxytryptamine in man . Br J Pharmacol 1978;5:13S-17S. 53. Baumann PA, Matre L: Blockade of presynaptic α-receptors and of amine uptake in the rat brain by the antidepressant mianserin . Naunyn Schmiedebergs Arch Pharmacol 1977;300:31-37.Crossref 54. Fludder JM, Leonard BE: Interaction between mianserin and clonidine in the rat brain in vivo . Commun Psychopharmacol 1978;2:487-490. 55. Fludder JM, Leonard BE: Chronic effects of mianserin on noradrenaline metabolism in the rat brain: Evidence for a pre-synaptic α-adrenolytic action in vivo . Psychopharmacology 1979;64:329-332.Crossref 56. Sugrue MF: Chronic antidepressants and rat brain monoamine adaptive changes . Trans Am Soc Neurochem 1980;11:208. 57. Robinson DS, Campbell IC, Walker M, et al: Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain . Neuropharmacology 1979;18:771-776.Crossref 58. Campbell IC, Robinson DS, Lovenberg W, et al: The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain . J Neurochem 1979;32:49-55.Crossref 59. Campbell IC, Colburn RW, Walker RW, et al: Norepinephrine and serotonin metabolism in the rat brain: Effects of chronic phenelzine administration , in Deniker P, Radouco-Thomas C, Villeneura A (eds): Neuro-psychopharmacology . New York, Pergamon Press, 1978, pp 629-640. 60. Campbell IC, Marshall EF: Effects of chronic regimens of phenelzine, tranylcypromine, and imipramine on rat brain norepinephrine and serotonin . J Pharmacol 1974;5( (suppl 2) ):14. 61. Musacchio JM, Julou L, Kety SS, et al: Increase in rat brain tyrosine hydroxylase activity produced by electroconvulsive shock . Proc Natl Acad Sci USA 1969;63:1117-1119.Crossref 62. Modigh K: Long-term effects on electroconvulsive shock therapy on synthesis turnover and uptake of brain monoamines . Psychopharmacology 1976;49:179-185.Crossref 63. Schildkraut JJ, Draskoczy PR, Sun Lo P: Norepinephrine pools in rat brain: Differences in turnover rates and pathways of metabolism . Science 1971;172:587-589.Crossref 64. Kety SS, Javoy F, Thierry AM, et al: A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat . Proc Natl Acad Sci USA 1969;58:1249-1254.Crossref 65. Ladisch W, Steinhauff N, Matussek N: Chronic administration of electroconvulsive shock and norepinephrine metabolism in the rat brain . Psychopharmacologia 1969;15:296-304.Crossref 66. Ebert MH, Baldessarini RJ, Lipinski JF, et al: Effects of electroconvulsive seizures on amine metabolism in the rat brain . Arch Gen Psychiatry 1973;29:397-401.Crossref 67. Aghajanian GK: Feedback regulation of central monoaminergic neurons: Evidence from single cell recording studies , in Youdim MBH, Lovenberg W, Sharman DR, et al (eds): Essays in Neurochemistry and Neuropharmacology . New York, John Wiley & Sons Inc, 1978, pp 1-31. 68. Corrodi H, Fuxe K: Decreased turnover in central 5-HT nerve terminals induced by antidepressant drugs of the imipramine type . Eur J Pharmacol 1969;7:56-59Crossref 69. Goodlet I, Sugrue MF: Effect of acutely administered analgesic drugs on rat brain serotonin turnover . Eur J Pharmacol 1974;29:241-248.Crossref 70. Marco EJ, Meek JL: The effects of antidepressants on serotonin turnover in discrete regions of rat brain . Naunyn Schmiedebergs Arch Pharmacol 1979;306:75-79.Crossref 71. Meek J, Werdinius B: Hydroxytryptamine turnover decreased by the antidepressant drug chlorimipramine . J Pharm Pharmacol 1970;22:141-143.Crossref 72. Modigh K: Effect of chlorimipramine on the rate of tryptophan hydroxylation in the intact and transected spinal cord . J Pharm Pharmacol 1973;25:926-928.Crossref 73. Leonard BE, Kafoe WF: A comparison of the acute and chronic effects of four antidepressant drugs on the turnover of serotonin, dopamine and noradrenaline in the rat brain . Biochem Pharmacol 1976;25:1939-1942.Crossref 74. Van Wijk M, Meisch JJ, Korf J: Metabolism of 5-hydroxytryptamine and levels of tricyclic antidepressant drugs in rat brain after acute and chronic treatment . Psychopharmacology 1977;55:217-223.Crossref 75. Kafoe WF, De Ridder JJ, Leonard BE: The effect of a tetracyclic antidepressant compound, Org GB94, on the turnover of biogenic amines in rat brain . Biochem Pharmacol 1976;25:2455-2460.Crossref 76. Alpers HS, Himwich HE: The effects of chronic imipramine administration on rat brain levels of serotonin, 5-hydroxyindoleacetic acid, norepi nephrine and dopamine . Pharmacol Exp Ther 1972;180:531-538. 77. Svensson TH: Attenuated feedback inhibition of brain serotonin synthesis following chronic administration of imipramine . Naunyn Schmiedebergs Arch Pharmacol 1978;302:115-118.Crossref 78. Sherman A: Time course of the effects of antidepressants on serotonin in rat neocortex . Commun Psychopharmacol 1979;3:1-5. 79. Sanghvi I, Gershon S: Effect of acute and chronic iprindole on serotonin turnover in mouse brain . Biochem Pharmacol 1975;24:2103-2104.Crossref 80. Fuxe K, Ogren SO, Agnati LF: The effects of chronic treatment with the 5-hydroxytryptamine uptake blocker zimelidine on central 5-hydroxy tryptamine mechanisms: Evidence for the induction of a low affinity binding site for 5-hydroxytryptamine . Neurosci Lett 1979;13:307-312.Crossref 81. Engel J, Hanson LCF, Roos B-E: Effect of electroshock on 5-HT metabolism in rat brain . Psychopharmacologia 1971;20:197-200.Crossref 82. Shields PJ: Effects of electroconvulsive shock on the metabolism of 5-hydroxytryptamine in rat brain . J Pharm Pharmacol 1972;24:919-921.Crossref 83. Hinsley RK, Norton JA, Aprison MH: Serotonin, norepinephrine, and 3,4,dihydroxyphenylethylamine in rat brain parts following electroconvul sive shock . J Psychiatr Res 1968;6:143-152.Crossref 84. Kato L, Gözsy B, Roy RB, et al: Histamine serotonin epinephrine and norepinephrine in rat brain, following convulsions . Int J Neuropsychiatry 1967;3:46-51. 85. Cooper AJ, Moir ATP, Goldberg HC: Effect of electroconvulsive shock on the cerebral metabolism of dopamine and 5-hydroxytryptamine . J Pharm Pharmacol 1968;20:729-730.Crossref 86. Feighner JP, Lao L, King LJ, et al: Brain serotonin and norepineph rine after convulsions and reserpine . J Neurochem 1972;19:905-907.Crossref 87. Tagliamonte A, Tagliamonte P, Di Chiara G, et al: Increase in brain tryptophan by electroconvulsive shock in rats . J Neurochem 1972;19:1509-1512.Crossref 88. Garattini S, Kato R, Lamesta L, et al: Electroshock, brain serotonin, and barbiturate narcosis . Experientia 1960;16:156-157.Crossref 89. Maas JW, Fawcett JA, Dekirmenjian H: Catecholamine metabolism, depressive illness, and drug response . Arch Gen Psychiatry 1972;26:252-262.Crossref 90. Goodwin FK, Post RM, Sack RL: Clinical evidence for neurochemical adaptation to psychotropic drugs , in Mandell AJ (ed): Neurobiological Mechanisms of Adaptation and Behavior . New York, Raven Press, 1975, pp 33-46. 91. Beckmann H, Goodwin FK: Antidepressant response to tricyclics and urinary MHPG in unipolar patients: Clinical response to imipramine and amitriptyline . Arch Gen Psychiatry 1975;32:17-21.Crossref 92. Perry GF, Fitzsimmons B, Shapiro L, et al: Clinical study of mianser in, imipramine, and placebo in depression: Blood level and MHPG correlations . Br J Clin Pharmacol 1978;5:35S-41S.Crossref 93. Cobbin DM, Requin-Blow B, Williams LR, et al: Urinary MHPG levels and tricyclic antidepressant drug selection: A preliminary communication on improved drug selection in clinical practice . Arch Gen Psychiatry 1979;36:1111-1115.Crossref 94. Halaris A, DeMet EM: Studies of norepinephrine metabolism in manic and depressive states , in Usdin E, Kopin IJ, Barchas J (eds): Catecholamines: Basic and Clinical Frontiers . New York, Pergamon Press, 1978, pp 1866-1868. 95. Veith RC, Bielski RJ, Friedel RO, et al: Urinary 3-methoxy-4-hydroxy-phenylglycol levels in depressed out-patients. Read before the 133rd annual meeting of the American Psychiatric Association, San Francisco, May 1980. 96. Beckmann H, Murphy DL: Phenelzine in depressed patients: Effects on urinary MHPG excretion in relation to clinical response . Neuropsycho-biology 1977;3:49-55.Crossref 97. Rosenbaum AH, Schatzberg AF, Maruta T, et al: MHPG as a predictor of antidepressant response to imipramine and maprotiline . Am J Psychiatry 1980;137:1090-1092. 98. Schildkraut J: Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: Preliminary findings . Am J Psychiatry 1973;130:695-699. 99. Sacchetti E, Smeraldi E, Cagnasso P, et al: MHPG, amitriptyline, and affective disorders: A longitudinal study . Int Pharmacopsychiatry 1976;11:157-162. 100. Modai I, Apter A, Golomb M, et al: Response to amitriptyline and urinary MHPG in bipolar depressed patients . Neuropsychobiology 1979;5:181-184.Crossref 101. Sacchetti E, Aliaria E, Negri F, et al: 3-Methoxy-4-hydroxyphenylgly-col and primary depression: Clinical and pharmacological considerations . Biol Psychiatry 1979;14:473-484. 102. Coppen A, Rama Rao VA, Ruthren CRJ, et al: Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitripty line in depressive illness . Psychopharmacology 1979;64:95-97.Crossref 103. Spiker DG, Edwards D, Hanin I, et al: Urinary MHPG and clinical response to amitriptyline in depressed patients . Am J Psychiatry 1980;137:1183-1187. 104. Hollister LE, Davis KL, Berger PA: Subtypes of depression based on excretion of MHPG and response to nortriptyline . Arch Gen Psychiatry 1980;37:1107-1110.Crossref 105. Siwers B, Ringberger VA, Tuck R, et al: Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients . Clin Pharmacol Ther 1976;21:194-200. 106. Bertilsson L, Asberg M, Thoren P: Differential effect of chlorimip ramine and nortriptyline on cerebrospinal fluid metabolites of serotonin and noradrenaline in depression . Eur J Clin Pharmacol 1976;21:194-200. 107. Asberg M, Ringberger VA, Sjoqvist F, et al: Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine . Clin Pharmacol Ther 1975;21:201-207. 108. Traskman L, Asberg M, Bertilsson L, et al: Plasma levels of chlor imipramine and its desmethyl metabolite during treatment of depression . Clin Pharmacol Ther 1979;26:600-610. 109. Post RM, Goodwin FK: Effects of amitriptyline and imipramine on amine metabolites in the cerebrospinal fluid of depressed patients . Arch Gen Psychiatry 1974;30:234-239.Crossref 110. Papeschi R, McClure DJ: Homovanillic and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients . Arch Gen Psychiatry 1971;25:354-358.Crossref 111. Bowers MB: Amitriptyline in man: Decreased formation of central 5-hydroxyindoleacetic acid . Clin Pharmacol Ther 1974;15:167-170. 112. Asberg M, Bertilsson L, Tuck D, et al: Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline . Clin Pharmacol Ther 1972;14:277-286. 113. Kupfer DJ, Bowers MB Jr: REM sleep and central monoamine oxidase inhibition . Psychopharmacologia 1972;27:182-190.Crossref 114. Bowers MB Jr, Kupfer DJ: Central monoamine oxidase inhibition and REM sleep . Brain Res 1971;35:561-564.Crossref 115. Nordin G, Ottosson JO, Roos BE: Influence of convulsive therapy on 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid in endogenous depression . Psychopharmacologia 1971;20:315-320.Crossref 116. Ashcroft GW, Crawford TBB, Eccleston D, et al: 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases . Lancet 1966;2:1049-1052.Crossref 117. Harnryd C, Bjerkenstedt L, Grimm VE, et al: Induction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment . Psychopharmacology 1979;64:131-134.Crossref 118. Abrams R, Essman WB, Taylor MA, et al: Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebro spinal fluid of depressed patients before and after ECT . Biol Psychiatry 1976;11:85-90. 119. Bowers MB, Heninger GR, Gerbode FA: Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients . Int J Neuropharmacol 1969;8:255-262.Crossref 120. Asberg M, Bertilsson L, Thoren P, et al: CSF monoamine metabolites in depressive illness , in Garattini S (chair): Depressive Disorders . Stuttgart, Germany, Friedrich-Karl Sehattauer Verlag, 1978, pp 293-305. 121. Van Praag HM: Biogenic amines: New evidence of serotonin-deficient depressions , in Garattini S (chair): Depressive Disorders . Stutt gart, Germany, Friedrich-Karl Sehattauer Verlag, 1978, pp 9-16. 122. Bertilsson L, Asberg M, Mellstrom B, et al: Factors determining drug effects in depressed patients: Studies of nortriptyline and chlorimipramine , in Garattini S (chair): Depressive Disorders . Stuttgart, Germany, Friedrich-Karl Sehattauer Verlag, 1978, pp 281-292. 123. Greengard P: Possible role for cyclic nucleotides and phosphorylated membrane proteins in postsynaptic actions of neurotransmitters . Nature 1976;260:101-108.Crossref 124. Sulser F: New perspectives on the mode of action of antidepressant drugs . Trends Pharmacol Sci 1979;1:92-94.Crossref 125. Baudry M, Martres MP, Schwartz JC: Modulation in the sensitivity of noradrenergic receptors in the CNS studied by the responsiveness of the cyclic AMP system . Brain Res 1976;116:111-124.Crossref 126. Schwartz JC, Costentin J, Martres MP, et al: Modulation of receptor mechanisms in the CNS: Hyper- and hypo-sensitivity to catecholamines . Neuropharmacology 1978;17:665-685.Crossref 127. Iversen LL: Catecholamine-sensitive adenylate cyclases in nervous tissues . J Neurochem 1977;29:5-12.Crossref 128. Kalisker A, Rutledge CO, Perkins JP: Effect of nerve degeneration by 6-hydroxydopamine on catecholamine-stimulated adenosine 3',5'-monophosphate formation in rat cerebral cortex . Mol Pharmacol 1973;9:619-629. 129. Blumberg JB, Vetulani J, Stawarz RJ, et al: The noradrenergic cyclic AMP generating system in the limbic forebrain: Pharmacological characterization in vitro and possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics . Eur J Pharmacol 1976;37:357-366.Crossref 130. Palmer GC, Robinson GA, Sulser F: Modification by psychotropic drugs of the cyclic adenosine monophosphate response to norepinephrine in rat brain . Biochem Pharmacol 1971;20:236-239.Crossref 131. Vetulani J, Stawarz RJ, Dingell JV, et al: A possible common mechanism of action of antidepressant treatments . Naunyn Schmiedebergs Arch Pharmacol 1976;293:109-114.Crossref 132. Mishra R, Sulser F: Role of serotonin reuptake inhibition in the development of subsensitivity of the norepinephrine (NE) receptor coupled adenylate cyclase system . Commun Psychopharmacol 1978;2:365-370. 133. Mishra R, Janowsky A, Sulser F: Action of mianserin and zimelidine on the norepinephrine receptor coupled adenylate cyclase system in brain: Subsensitivity without reduction in β-adrenergic receptor binding . Neuropharmacology 1980;19:983-987.Crossref 134. Wolfe BB, Harden TK, Sporn JR, et al: Presynaptic modulation of beta-adrenergic receptors in rat cerebral cortex after treatment with antidepressants . J Pharmacol Exp Ther 1978;207:446-457. 135. Carlsson A, Corrodi H, Fuxe K, et al: Effects of some antidepressants on the depletion of intraneuronal brain catecholamine stores caused by 4-α-dimethylmetatyramine . Eur J Pharmacol 1969;5:367-373.Crossref 136. Horn AS: The interaction of tricyclic antidepressants with biogenic amine uptake systems in the central nervous system . Postgrad Med J 1976;52( (suppl 3) ):25-32. 137. Glowinski J, Axelrod J: Inhibition of uptake of tritiated noradrenaline in the intact rat brain by imipramine and structurally related compounds . Nature 1964;204:1318-1319.Crossref 138. Ross SB, Renyi A: Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents . Eur J Pharmacol 1967;2:181-186.Crossref 139. Nahorski SR: Altered responsiveness of cerebral β-adrenoreceptors assessed by adenosine cyclic 3',5'-monophosphate formation and 3H-propranolol binding . Mol Pharmacol 1977;13:679-689. 140. Vetulani J, Sulser F: Action of various antidepressant treatments reduce reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain . Nature 1975;257:495-496.Crossref 141. Vetulani J, Stawarz RJ, Sulser F: Adaptive mechanisms of the noradrenergic cyclic AMP generating system in the limbic forebrain of the rat: Adaptation to persistent changes in the availability of norepinephrine (NE) . J Neurochem 1976;27:661-666.Crossref 142. Dolphin A, Sawaya CB, Jenner P, et al: Behavioural and biochemical effects of chronic reduction of cerebral noradrenaline receptor stimulation . Naunyn Schmiedebergs Arch Pharmacol 1977;299:167-173.Crossref 143. Ross SB, Renyi AL, Ogren SO: A comparison of the inhibiting activities of iprindole and imipramine on the uptake of 5-hydroxytryptamine and noradrenaline in brain slices . Life Sci 1971;10:1267-1277.Crossref 144. Georgotas A, Mann J, Bush D, et al: A clinical trial of zimelidine in depression . Commun Psychopharmacol 1980;4:71-77. 145. Aberg A, Holmburg G: Preliminary clinical test of zimelidine, a new 5-HT uptake inhibitor . Acta Psychiatr Scand 1979;59:45-58.Crossref 146. Schmidt MJ, Thornberry JF: Norepinephrine-stimulated cyclic AMP accumulation in brain slices in vitro after serotonin depletion or chronic administration of selective amine reuptake inhibitors . Arch Int Pharmacodyn Ther 1977;229:42-51. 147. Schultz J, Daly JW: Accumulation of cyclic adenosine 3',5'-monophosphate in cerebral cortical slices from rat and mouse: Stimulatory effect of aand β-adrenergic agents and adenosine . J Neurochem 1973;21:1319-1326.Crossref 148. Mobley PL, Sulser F: Norepinephrine stimulated cyclic AMP accumulation in rat limbic forebrain slices: Partial mediation by a subpopulation of receptors with neither α nor β characteristics . Eur J Pharmacol 1979;60:221-227.Crossref 149. Gillespie DD, Manier DH, Sulser F: Electroconvulsive treatment: Rapid subsensitivity of the norepinephrine receptor coupled adenylate cyclase system in brain linked to down regulation of β-adrenergic receptors . Commun Psychopharmacol 1979;3:191-194. 150. Jones DJ, McKenna LF: Cyclic AMP formation in rat spinal cord tissue slices . Neuropharmacology 1980;19:669-674.Crossref 151. Skolnick P, Daly JW: Stimulation of adenosine 3',5'-monophosphate formation in rat cerebral cortical slices by methoxamine: Interaction with an alpha adrenergic receptor . J Pharmacol Exp Ther 1975;193:549-558. 152. Daly JW, Padgett W, Nimitkitpaisan Y, et al: Fluoronorepinephrines: Specific agonists for the activation of alpha and beta adrenergicsensitive cyclic AMP-generating systems in brain slices . J Pharmacol Exp Ther 1980;212:382-389. 153. Palmer GC, Robison GA, Manian AA, et al: Modification by psychotropic drugs of the cyclic AMP response to norepinephrine in the rat brain in vitro . Psychopharmacologia 1972;23:201-211.Crossref 154. Kakiuchi S, Rall TW: The influence of chemical agents on the accumulation of adenosine 3',5'-phosphate in slices of rabbit cerebellum . Mol Pharmacol 1968;4:367-378. 155. Palmer GC, Sulser F, Robison GA: Effects of neurohumoral and adrenergi, [ill] on cyclic AMP levels in various areas of the rat brain in vitro . Neuropharmacology 1973;12:327-337.Crossref 156. Huang M, Ho AKS, Daly JR: Accumulation of adenosine cyclic 3',5'-monophosphate in rat cerebral cortical slices: Stimulatory effect of alpha and beta adrenergic agents after treatment with 6-hydroxydopamine, 2,3,5,-trihydroxyphenethylamine, and dihydroxytryptamine . Mol Pharmacol 1973;9:711-717. 157. Sattin A: Increased activity of adenosine-stimulated adenylate cyclase in cortex following electroconvulsive seizures (ECT) . Neurosci Abstr 1980;6:720. 158. Schultz J: Psychoactive drug effects on a system which generates cyclic AMP in brain . Nature 1976;261:417-418.Crossref 159. Raskin A, Schulterbrandt JG, Reatig N, et al: Differential response to chlorpromazine, imipramine, and placebo: A study of subgroups of hospitalized depressed patients . Arch Gen Psychiatry 1970;23:164-173.Crossref 160. Korf J, Sebens JB, Postema F: Cyclic AMP in the rat cerebral cortex after stimulation of the locus coeruleus: Decrease by antidepressant drugs . Eur J Pharmacol 1979;59:23-30.Crossref 161. Minneman KP, Quik M, Emson PC: Receptor-linked cyclic AMP systems in rat neostriatum: Differential localization revealed by kinic acid injection . Brain Res 1978;151:507-521.Crossref 162. Palmer GC, Wagner MR, Putnam RW: Neuronal localization of the enhanced adenylate cyclase responsiveness to catecholamines in rat cerebral cortex following reserpine injections . Neuropharmacology 1976;15:695-702.Crossref 163. Partington CR, Edwards MW, Daly JW: Regulation of cyclic AMP formation in brain tissue by alpha-adrenergic receptors: Requisite intermediacy of prostaglandins of the E series . Proc Natl Acad Sci USA 1980;77:3024-3028.Crossref 164. Bockaert J, Tassin JP, Thierry AM, et al: Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat: Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases . Brain Res 1977;122:71-86.Crossref 165. Dolphin A, Adrien J, Hamon M, et al: Identity of 3H-dihydroalprenolol binding sites and β-adrenergic receptors coupled with adenylate cyclase in the central nervous system: Pharmacological properties, distribution and adaptive responsiveness . Mol Pharmacol 1979;15:1-15. 166. Jones RSG: Noradrenaline sensitive adenylate cyclase in rat cerebral cortex: Effects of antidepressant drugs . Neuropharmacology 1978;17:771-774.Crossref 167. Türck M, Schocker WF, Fathy AM, et al: Adrenergic subsensitivity of a cell-free adenylate cyclase from rat brain after chronic imipramine treatment . Arch Pharm 1980;313:768-773.Crossref 168. Frazer A, Mendels J: Do tricyclic antidepressants enhance adrenergic transmission? Am J Psychiatry 1977;134:1040-1042. 169. Frazer A, Pandey G, Mendels J, et al: The effect of tri-iodothyronine in combination with imipramine on 3H-cyclic AMP production in slices of rat cerebral cortex . Neuropharmacology 1974;13:1131-1140.Crossref 170. Frazer A, Hess ME, Mendels J, et al: Influence of acute and chronic treatment with desmethylimipramine on catecholamine effects in the rat . J Pharmacol Exp Ther 1978;206:311-319. 171. Banerjee SP, Kung LS, Riggi SJ, et al: Development of β-adrenergic receptor subsensitivity by antidepressants . Nature 1977;268:455-456.Crossref 172. Vogel GW, Vogel F, McAbee RS, et al: Improvement of depression by REM sleep deprivation: New findings and a theory . Arch Gen Psychiatry 1980;37:247-253.Crossref 173. Mogilnicka E, Arbilla S, Depoortere H, et al: Rapid-eye-movement sleep deprivation decreases the density of 3H-dihydroalprenolol and 3H-imipramine binding sites in the rat cerebral cortex . Eur J Pharmacol 1980;65:289-292.Crossref 174. Bergstrom DA, Kellar KJ: Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment . J Pharmacol Exp Ther 1979;209:256-261. 175. Peroutka SJ, Snyder SH: Regulation of serotonin2 (5-HT2) receptors labeled with 3H-spiroperidol by chronic treatment with the antidepressant amitriptyline . J Pharmacol Exp Ther 1980;215:582-587. 176. Sellinger-Barnette MM, Mendels J, Frazer A: The effect of psychoactive drugs on beta-adrenergic receptor binding sites in rat brain . Neuropharmacology 1980;19:447-454.Crossref 177. Peroutka SJ, Snyder SH: Chronic antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding . Science 1980; 210:88-90.Crossref 178. Sellinger M, Sarai K, Frazer A, et al: Beta adrenergic receptor binding in rat cerebral cortex after repeated administration of psychotropic drugs . Fed Proc 1978;37:309. 179. Clements-Jewery S: The development of cortical β-adrenoceptor subsensitivity in the rat by chronic treatment with trazodone, doxepin, and mianserin . Neuropharmacology 1978;17:779-781.Crossref 180. Rehavi M, Ramot O, Yavetz B, et al: Amitriptyline: Long-term treatment elevates α-adrenergic and muscarinic receptor binding in mouse brain . Brain Res 1980;194:443-453.Crossref 181. Rosenblatt JE, Pert CB, Tallman JF, et al: The effect of imipramine and lithium on α- and β-receptor binding in rat brain . Brain Res 1979;160:186-191.Crossref 182. Tang SW, Seeman P: Effect of antidepressant drugs on serotonergic and adrenergic receptors . Naunyn Schmiedebergs Arch Pharmacol 1980;311:255-261.Crossref 183. U'Prichard DC, Greenberg DA, Sheehan PP, et al: Tricyclic antidepressants: Therapeutic properties and affinity for α-noradrenergic receptor binding sites in the brain . Science 1978;199:197-198.Crossref 184. Johnson RW, Reisine T, Spotnitz S, et al: Effects of desipramine and yohimbine on α2 and β-adrenoceptor sensitivity . Eur J Pharmacol 1980;67:123-127.Crossref 185. Reisine TD, U'Prichard DC, Wiech NL, et al: Effects of combined administration of amphetamine and iprindole on brain adrenergic receptors . Brain Res 1980;188:587-592.Crossref 186. Smith CB, Garcia-Sevilla JA, Hollingsworth PJ: Alpha-2 adrenoceptors in rat brain are decreased after long-term tricyclic antidepressant drug treatment . Brain Res 1981;210:413-418.Crossref 187. Vetulani J, Pik A, Nikitin K: The effect of chronic imipramine treatment of rats on 3H-clonidine binding in the brain . Prog Neuropsychopharmacol 1980;12( (suppl 1) ):349. 188. Campbell IC, Murphy DL, Gallager DW, et al: Neurotransmitterrelated adaptation in the central nervous system following chronic monoamine oxidase inhibition , in Singer TP, Von Korff RW, Murphy DL (eds): Monoamine Oxidase: Structure, Function, and Altered Functions . New York, Academic Press Inc, 1979, pp 517-530. 189. Fuxe K, Ogren S-O, Agnati LF: The effects of chronic treatment with the 5-hydroxytryptamine uptake blocker zimelidine on central 5hydroxytryptamine mechanisms: Evidence for the induction of a low affinity binding site for 5-hydroxytryptamine . Neurosci Lett 1979;13:307-312.Crossref 190. De Montigny C, Blier P, Caille G, et al: Pre- and postsynaptic effects of zimelidine and norzimelidine on the serotoninergic system: Single cell studies in the rat . Acta Psychiatr Scand 1981;63( (suppl 290) ):79-90.Crossref 191. Peroutka SJ, Snyder SH: Multiple serotonin receptors: Differential binding of 3H-5-hydroxytryptamine, 3H-lysergic acid diethylamide and 3H-spiroperidol . Mol Pharmacol 1979;16:687-699. 192. Tang SW, Seeman P, Kwan S: Effect of chronic tricyclic antidepressant treatment on serotonergic and histaminergic receptors . Neurosci Abstr 1980;6:861. 193. Blackshear MA, Steranka R, Sanders-Bush E: Serotonin receptor subtypes after chronic treatment with tricyclic antidepressant drugs . Neurosci Abstr 1980;6:860. 194. Mann E, Enna SJ: Neurochemical and behavioral correlates of antidepressant drug action . Neurosci Abstr 1980;6:800. 195. Kellar KJ, Cascio CS, Butler JA, et al: Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain . Eur J Pharmacol 1981;69:515-518.Crossref 196. Nielsen EB, Nielsen M, Ellison G, et al: Decreased spiroperidol and LSD binding in rat brain after continuous amphetamine . Eur J Pharmacol 1980;66:149-154.Crossref 197. Middlemiss JA, Carroll JA, Fisher RW, et al: Does 3H-spiroperidol label a 5-HT receptor in the frontal cortex of the rat? Eur J Pharmacol 1980;60:253-254.Crossref 198. Snyder SH, Yamamura HI: Antidepressants and the muscarinic acetylcholine receptor . Arch Gen Psychiatry 1977;34:236-239.Crossref 199. Maggi A, U'Prichard DC, Enna SJ: Differential effects of antidepressant treatment on brain monoaminergic receptors . Eur J Pharmacol 1980;61:91-98.Crossref 200. Savage DD, Frazer A, Mendels J: Differential effects of monoamine oxidase inhibitors and serotonin reuptake inhibitors on 3H-serotonin receptor binding in rat brain . Eur J Pharmacol 1979;58:87-88.Crossref 201. Wirz-Justice A, Krauchi K, Lichtsteiner M, et al: Is it possible to modify serotonin receptor sensitivity? Life Sci 1978;23:1249-1254.Crossref 202. Sarai K: Desmethylimipramine-induced decrease in β-adrenergic receptor binding in rat cerebral cortex . Biochem Pharmacol 1978;27:2179-2181.Crossref 203. Minneman KP, Wolfe BB, Dibner MD, et al: β1- And β2-adrenergic receptors in rat cerebral cortex are independently regulated . Science 1979204:866-868.Crossref 204. Schweitzer JW, Schwartz R, Friedhoff AJ: Intact presynaptic terminals required for beta-adrenergic receptor regulation by desipramine . J Neurochem 1979;33:377-379.Crossref 205. Wirz-Justice A, Kafka MS, Naber D, et al: Circadian rhythms in rat brain alpha- and beta-adrenergic receptors are modified by chronic imipramine . Life Sci 1980;27:341-347.Crossref 206. Segawa T, Mizuta T, Nomura Y: Modifications of central 5-hydroxytryptamine binding sites in synaptic membranes from rat brain after long-term administration of tricyclic antidepressants . Eur J Pharmacol 1979;58:75-83.Crossref 207. Bergstrom DA, Kellar KJ: Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain . Nature 1979;278:464-466.Crossref 208. Pandey GN, Heinze WJ, Brown BD, et al: Electroconvulsive shock treatment decreases β-adrenergic receptor sensitivity in rat brain . Nature 1979;280:234-235.Crossref 209. Aghajanian GK: Tricyclic antidepressants and single cell responses to serotonin and norepinephrine: A review of chronic studies , in Usdin E, Bunney WE, Davis JM (eds): Neuroreceptors: Basic and Clinical Aspects . New York, John Wiley & Sons Inc, 1981, pp 27-35. 210. Dillier N, Laszlo J, Muller B, et al: Activation of an inhibitory noradrenergic pathway projecting from the locus coeruleus to the cingulate cortex of the rat . Brain Res 1978;154:61-68.Crossref 211. Hoffer BJ, Siggins GR, Bloom FE: Studies on norepinephrinecontaining afferents to Purkinje cells of rat cerebellum: II. Sensitivity of Purkinje cells to norepinephrine and related substances administered by microiontophoresis . Brain Res 1971;25:523-534.Crossref 212. Segal M, Bloom FE: The action of norepinephrine in the rat hippocampus: I. Iontophoretic studies . Brain Res 1974;72:79-97.Crossref 213. DeMontigny C, Aghajanian GK: Tricyclic antidepressants: Longterm treatment increases responsivity of rat forebrain neurons to serotonin . Science 1978;202:1303-1306.Crossref 214. Gallager DW, Bunney WE Jr: Failure of chronic lithium treatment to block tricyclic antidepressant-induced 5-HT supersensitivity . Naunyn Schmiedebergs Arch Pharmacol 1979;307:129-133.Crossref 215. Huang YH: Chronic desipramine treatment increases activity of noradrenergic postsynaptic cells . Life Sci 1979;25:709-716.Crossref 216. Rogawski MA, Aghajanian GK: Activation of lateral geniculate neurons by norepinephrine: Mediation by an α-adrenergic receptor . Brain Res 1980;182:345-359.Crossref 217. Menkes DB, Aghajanian GK, McCall RB: Chronic antidepressant treatment enhances α-adrenergic and serotonergic responses in the facial nucleus . Life Sci 1980;27:45-55.Crossref 218. Menkes DB, Aghajanian GK: Alpha-l-adrenoceptor-mediated responses in the lateral geniculate nucleus are enhanced by chronic antidepressant treatment . Eur J Pharmacol , to be published. 219. Wang RY, Aghajanian GK: Enhanced sensitivity of amygdaloid neurons to serotonin and norepinephrine after chronic antidepressant treatment . Commun Psychopharmacol 1980;4:83-90. 220. Horn AS: Structure activity relations for the inhibition of 5-HT uptake into rat hypothalamic homogenates by serotonin and tryptamine analogues . J Neurochem 1973;21:883-888.Crossref 221. Ross SB, Renyi AL: Inhibition of the uptake of tritiated 5-HT in brain tissue . Eur J Pharmacol 1969;4:270-277.Crossref 222. DeMontigny C: Electroconvulsive shock treatment increases responsiveness of forebrain neurons to serotonin: A microiontophoretic study in the rat . Neurosci Abstr 1980;6:453. 223. Olpe HR: Differential effects of chlorimipramine and clorgyline on the sensitivity of cortical neurons to serotonin: Effect of chronic treatment . Eur J Pharmacol 1981;69:375-377.Crossref 224. Blier P, de Montigny C: Effect of chronic tricyclic antidepressant treatment on the serotoninergic autoreceptor: A microiontophoretic study in the rat . Naunyn Schmiedebergs Arch Pharmacol 1980;314:123-128.Crossref 225. Aghajanian CK, Wang RY: Physiology and pharmacology of central serotonergic neurons , in Lipton MA, DeMascio A, Killam KF (eds): Psychopharmacology: A Generation of Progress . New York, Raven Press, 1978, pp 171-184. 226. Sheard MH, Zolovick A, Aghajanian GK: Raphe neurons: Effect of tricyclic antidepressant drugs . Brain Res 1972;43:690-694.Crossref 227. Chiodo LA, Antelman SA: Repeated tricyclics induced a progressive dopamine autoreceptor subsensitivity independent of daily drug treatment . Nature 1980;287:451-454.Crossref 228. Chiodo LA, Antelman SA: Electroconvulsive shock: Progressive dopamine auto-receptor subsensitivity independent of repeated treatment . Science 1980;210:799-801.Crossref 229. Olpe HR, Schellenberg A: Reduced sensitivity of neurons to noradrenaline after chronic treatment with antidepressant drugs . Eur J Pharmacol 1980;63:7-13.Crossref 230. Jones RSG: Long-term administration of atropine, imipramine, and viloxazine alters responsiveness of rat cortical neurons to acetylcholine . Can J Physiol 1980;58:531-535.Crossref 231. Siggins GR, Schultz JE: Chronic treatment with lithium or desipramine alters discharge frequency and norepinephrine responsiveness of cerebellar Purkinje cells . Proc Natl Acad Sci USA 1979;76:5987-5991.Crossref 232. Schultz JE, Siggins GR, Schocker FW, et al: Effects of prolonged treatment with lithium and tricyclic antidepressants on discharge frequency, norepinephrine responses and beta receptor binding in rat cerebellum: Electrophysiological and biochemical comparison . J Pharmacol Exp Ther 1981;216:28-38. 233. Modigh K: Electroconvulsive shock and postsynaptic catecholamine effects: Increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS . J Neural Transm 1975;36:19-32.Crossref 234. Maj J, Mogilnicka E, Klimek V: The effect of repeated administration of antidepressant drugs on the responsiveness of rats to catecholamine agonists . J Neural Transm 1979;44:221-235.Crossref 235. Maj J, Mogilnicka E, Kordecka A: Chronic treatment with antidepressant drugs: Potentiation of apomorphine-induced aggressive behaviour in rats . Neurosci Lett 1979;13:337-341.Crossref 236. Maj J, Mogilnicka E, Kordecka-Magiera A: Effects of chronic administration of antidepressant drugs on aggressive behavior induced by clonidine in mice . Pharmacol Biochem Behav 1979;13:153-154.Crossref 237. Anden N-E, Strombom U, Svensson TH: Dopamine and noradrenaline receptor stimulation: Reversal of reserpine-induced suppression of motor activity . Psychopharmacologia 1973;29:289-298.Crossref 238. Morpurgo C: Aggressive behavior induced by large doses of 2(2,6-dichlorphenyl-amino)-2-imidazoline hydrochloride (St 155) in mice . Eur J Pharmacol 1968;3:374-378.Crossref 239. Maj J, Mogilnicka E, Klimek V: Dopaminergic stimulation enhances the utilization of noradrenaline in the central nervous system . J Pharm Pharmacol 1977;29:569-570.Crossref 240. Mogilnicka E, Klimek V: Mianserin, danitracen and amitriptyline withdrawal increases the behavioural responses of rats to L-5-HTP . J Pharm Pharmacol 1979;31:704-705.Crossref 241. Friedman E, Dallob A: Enhanced serotonin receptor activity after chronic treatment with imipramine or amitriptyline . Commun Psychopharmacol 1979;3:89-92. 242. Jones RSG: Enhancement of 5-hydroxytryptamine-induced behavioral effects following chronic administration of antidepressant drugs . Psychopharmacology 1980;69:307-311.Crossref 243. Evans JPM, Grahame-Smith DG, Green AR, et al: Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs . Br J Pharmacol 1976;56:193-199.Crossref 244. Green AR, Heal DJ, Grahame-Smith DG: Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5hydroxytryptamine and dopamine . Psychopharmacology 1977;52:195-200.Crossref 245. Grahame-Smith DG, Green AR, Costain DW: Mechanism of the antidepressant action of electroconvulsive therapy . Lancet 1978;1:254-257.Crossref 246. Costain DW, Green AR, Grahame-Smith DG: Enhanced 5-hydroxytryptamine-mediated behavioural responses in rats following repeated electroconvulsive shock: Relevance to the mechanism of the antidepressive effect of electroconvulsive therapy . Psychopharmacology 1979;61:167-170.Crossref 247. Green AR, Deakin JFW: Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour . Nature 1980;285:232-233.Crossref 248. Fuxe K, Ogren S-O, Agnati L, et al: On the mechanism of action of the antidepressant drugs amitriptyline and nortriptyline: Evidence for 5-hydroxytryptamine receptor blocking activity . Neurosci Lett 1977;6:339-344.Crossref 249. Maj J, Lewandowska A, Rawlow A: Central antiserotonin action of amitriptyline . Pharmakopsychiatr Neuropsychopharmakol 1979;12:281-285.Crossref 250. Maj J, Sowinska H, Baran L, et al: The antiserotonin actions of mianserin . Psychopharmacology 1978;59:79-84.Crossref 251. Peet M, Coppen A: The pharmacokinetics of antidepressant drugs: Relevance to their therapeutic effect , in Paykel ES, Coppen A (eds): Psychopharmacology of Affective Disorders . New York, Oxford University Press Inc, 1979, pp 91-107. 252. Sachar EJ: Twenty-four hour cortisol patterns in depressed and manic patients . Prog Brain Res 1975;42:81-91. 253. Carrol BJ, Mendels J: Neuroendocrine regulation in depression , in Sachar E (ed): Hormones, Behavior and Psychopathology . New York, Raven Press, 1976, pp 192-224. 254. Sachar EJ, Hellman L, Roffwarg HP, et al: Disrupted 24-hour patterns of cortisol secretion in psychotic depression . Arch Gen Psychiatry 1973;28:19-24.Crossref 255. Carroll BJ, Curtis GC, Mendels J: Neuroendocrine regulation in depression: I. Limbic system-adrenocortical dysfunction . Arch Gen Psychiatry 1976;33:1039-1044.Crossref 256. Carroll BJ, Curtis GC, Mendels J: Neuroendocrine regulation in depression: II. Discrimination of depressed from nondepressed patients . Arch Gen Psychiatry 1976;33:1051-1058.Crossref 257. Checkley SA: Corticosteroid and growth hormone responses to methylamphetamine in depressive illness . Psychol Med 1978;8:1-9.Crossref 258. Sachar EJ, Asnis G, Nathan S, et al: Dextroamphetamine and cortisol in depression: Morning plasma cortisol levels suppressed . Arch Gen Psychiatry 1980;37:755-757.Crossref 259. Brown WA, Shuey I: Response to dexamethasone and subtype of depression . Arch Gen Psychiatry 1980;37:747-751.Crossref 260. Schlesser MA, Winokur G, Sherman BM: Hypothalamic-pituitaryadrenal axis activity in depressive illness: Its relationship to classification . Arch Gen Psychiatry 1980;37:737-743.Crossref 261. Greden JF, Tarika JS, Devigne J-P, et al: Dexamethasone test predicts treatment response. Read before the 133rd annual meeting of the American Psychiatric Association, San Francisco, May 1980. 262. Goldberg IK: Dexamethasone suppression test as indicator of safe withdrawal of antidepressant therapy . Lancet 1980;1:376.Crossref 263. Mueller PS, Heninger GR, McDonald RK: Insulin tolerance test in depression . Arch Gen Psychiatry 1969;21:587-594.Crossref 264. Carroll BJ: Studies with hypothalamic-pituitary-adrenal stimulation tests in depression , in Davies B, Carroll BJ, Mowbray RM (eds): Depressive Rlness: Some Research Studies . Springfield, Ill, Charles C Thomas Publisher, 1972, pp 149-201. 265. Sachar EJ, Finkelstein J, Hellman L: Growth hormone responses in depressive illness: I. Response to insulin tolerance test . Arch Gen Psychiatry 1971;25:263-269.Crossref 266. Gruen PH, Sachar EJ, Altman N, et al: Growth hormone responses to hypoglycemia in postmenopausal depressed women . Arch Gen Psychiatry 1975;32:31-33.Crossref 267. Endo M, Endo J, Nishikubo M, et al: Endocrine studies in depression , in Hatotani N (ed): Psychoneuroendocrinology . New York, S Karger AG, 1974, pp 22-31. 268. Czernik A, Kleesick K: Insulin-sensitivity and pituitary hormone secretion in the course of depressive syndromes , in Radouco-Thomas C, Garcia F (eds): Progress in Neuro-Psychopharmacology . New York, Pergamon Press, 1980, vol 12, suppl 1, p 120. 269. Blackard WJ, Heidingsfelder A: Adrenergic receptor control mechanism for growth hormone secretion . J Clin Invest 1968;47:1407-1414.Crossref 270. Bivens CH, Lebovits HE, Feldman JM: Inhibition of hypoglycemia induced growth hormone secretion by the serotonin antagonists cyproheptadine and methysergide . N Engl J Med 1973;289:236-239.Crossref 271. Langer G, Heinze G, Reim B, et al: Reduced growth hormone responses to amphetamine in 'endogenous' depressive patients: Studies in normal, 'reactive' and 'endogenous' depressive, schizophrenic, and chronic alcoholic subjects . Arch Gen Psychiatry 1970;33:1471-1475.Crossref 272. Matussek N, Ackenheil M, Hippius H, et al: Effect of clonidine on growth hormone release in psychiatric patients and controls . Psychiatr Res 1980;2:25-36.Crossref 273. Checkley SA: Corticosteroid and growth hormone responses to methylamphetamine in depressive illness . Psychol Med 1979;9:107-115.Crossref 274. Checkley SA, Slade AP, Shur E: Growth hormone and other responses to clonidine in patients with endogenous depression . Br J Psychiatry 1981;138:51-55.Crossref 275. Checkley SA, Slade AP, Shur E, et al: A pilot study of the mechanism of action of desipramine . Br J Psychiatry 1981;138:248-251.Crossref 276. Loosen PT, Prange AJ Jr: Thyrotropin releasing hormone (TRH): A useful tool for psychoneuroendocrine investigation . Psychoneuroendocrinology 1980;5:63-80.Crossref 277. Gregoire F, Brauman H, de Buck R, et al: Hormone release in depressed patients before and after recovery . Psychoneuroendocrinology 1977;2:303-312.Crossref 278. Kirkegaard C, Bjorum N, Cohn D, et al: Studies on the influence of biogenic amines and psychoactive drugs on the prognostic value of the TRH stimulation test in endogenous depressoin . Psychoneuroendocrinology 1977;2:131-136.Crossref 279. Kirkegaard C, Smith E: Continuation therapy in endogenous depression controlled by changes in the TRH stimulation test . Psychol Med 1978;8:501-503.Crossref 280. Kirkegaard C, Norlem N, Lauridsen UB, et al: Prognostic value of thyrotropin-releasing hormone stimulation test in endogenous depression . Acta Psychiatr Scand 1975;52:170-177.Crossref 281. Takahashi S, Kondo H, Yoshimura M, et al: Growth hormone responses to administration of L-5-hydroxytryptophan (L-5-HTP) in manicdepressive psychoses . Folia Psychiatr Neurol Jpn 1973;27:197-206. 282. Kato Y, Nakai Y, Imura H, et al: Effects of 5-hydroxytryptophan on plasma prolactin levels in man . J Clin Endocrinol Metab 1974;38:695-697.Crossref 283. Sachar EJ, Nathan RS, Asnis G, et al: Neuroendocrine studies of major depressive disorder . Acta Psychiatr Scand 1980;61( (suppl 260) ):201-210. 284. Cavagnini F, Raggi V, Micossi P, et al: Effect of an antiserotonergic drug metergoline on the ACTH and cortisol response to insulin hypoglycemia and lysine vasopressin in man . J Clin Endocrinol Metab 1976;43:306-312.Crossref 285. Krulich L: The role of central monoamines in stress-related changes of the secretion of prolactin and TSH . Psychopharmacol Bull 1976;12( (Oct) ):22-24. 286. Coppen A, Rao Rama VA, Bishop M, et al: Neuroendocrine studies in affective disorders: I. Plasma prolactin response to thyrotropin-releasing hormone in affective disorders: Effect of ECT . J Affect Disord 1980;2:311-315.Crossref 287. Prange AJ, McCurdy RL, Cochrane CM: The systolic blood pressure response of depressed patients to infused norepinephrine . Psychiatr Res 1967;5:1-13.Crossref 288. Pickar D, Cohen RM, Murphy DL, et al: Tyramine infusions in bipolar illness: Behavioral effects and longitudinal changes in pressor sensitivity . Am J Psychiatry 1979;136:1460-1464. 289. Chose K, Coppen'A, Turner P: Autonomic actions and interactions of mianserin hydrochloride (Org. GB 94) and amitriptyline in patients with depressive illness . Psychopharmacology 1976;49:201-204.Crossref 290. Coppen A, Ghose K: Peripheral α-adrenoreceptor and central dopamine receptor activity in depressive patients . Psychopharmacology 1978;59:171-177.Crossref 291. Fann WE, Davis JM, Janowsky DS, et al: Effect of antidepressant and antimanic drugs on amine uptake in man . J Nerv Ment Dis 1974;158:361-368.Crossref 292. Freyschuss U, Sjoqvist F, Tuck D: Tyramine pressor effects in man before and during treatment with nortriptyline or ECT: Correlation between plasma level and effect of nortriptyline . Pharmacol Clin 1970;2:72-78.Crossref 293. Bevan P, Bradshaw CM, Szabadi E: The pharmacology of adrenergic neuronal responses in the cerebral cortex: Evidence for excitatory α- and inhibitory β-receptors . Br J Pharmacol 1977;59:635-641.Crossref 294. Waterhouse BD, Moises HC, Woodward DJ: Alpha, beta pharmacological characterization of noradrenergic modulatory actions in rat somatosensory cortex . Neurosci Abstr 1979;5:356. 295. Rees L, Butler PWP, Gosling C, et al: Adrenergic blockade and the corticosteroid and growth hormone responses to methylamphetamine . Nature 1970;288:565-566.Crossref 296. Imura H, Kato Y, Ikeda M, et al: Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin and blood free fatty acid levels in man . J Clin Invest 1971;50:1069-1079.Crossref 297. Hoffman BB, Lefkowitz RJ: Radioligand binding studies of adrenergic receptors . Ann Rev Pharmacol Toxicol 1980;20:581-608.Crossref 298. Maggi A, U'Prichard DC, Enna SJ: β-Adrenergic regulation of α-adrenergic receptors in the central nervous system . Science 1980;207:645-647.Crossref 299. U'Prichard DC, Kvetnansky R: Central and peripheral adrenergic receptors in acute and repeated immobilization stress , in Kopin IF, Usdin E, Kvetnansky R (eds): Second International Symposium on Catecholamines and Stress . New York, Elsevier North Holland Inc, to be published. 300. Pujol JF, Keane P, McRae A, et al: Biochemical evidence for serotonergic control of the locus coeruleus , in Garattini S, Pujol JF, Samanin R (eds): Interactions Between Putative Neurotransmitters in the Brain . New York, Raven Press, 1978, pp 401-410. 301. Roizen MF, Jacobowitz DM: Studies on the origin of innervation of the noradrenergic area bordering on the nucleus raphe dorsalis . Brain Res 1976;101:561-568.Crossref 302. Fuxe K: Evidence for the existence of monoamine nerve terminals in the central nervous system: IV. Distribution of monoamine nerve terminals in the central nervous system . Acta Physiol Scand 1965;64( (suppl 247) ):37-85.Crossref 303. Hokfelt T, Fuxe K, Goldstein M, et al: Immunohistochemical evidence for the existence of adrenaline neurons in the rat brain . Brain Res 1974;66:235-251.Crossref 304. Swanson LW, Hartman BK: The central adrenergic system: An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-β-hydroxylase as a marker . J Comp Neurol 1975;163:467-506.Crossref 305. Hokfelt T, Johansson O, Fuxe K, et al: Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain: I. Tyrosine hydroxylase in the mesencephalon and diencephalon . Med Biol 1976;54:427-453. 306. Descarries L, Leger L: Serotonergic nerve terminals in the locus coeruleus of the adult rat , in Garattini S, Pujol JF, Samanin R (eds): Interactions Between Putative Neurotransmitters in the Brain . New York, Raven Press, 1978, pp 355-368. 307. Baraban JM, Aghajanian GK: EM autoradiographic studies of adrenergic input to the dorsal raphe . Neurosci Abstr 1979;5:329. 308. Svensson TH, Bunney BS, Aghajanian GK: Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine . Brain Res 1975;92:291-306.Crossref 309. Gallager DW, Aghajanian GK: Effect of antipsychotic drugs on the firing of dorsal raphe cells: I. The role of adrenergic system . Eur J Pharmacol 1976;39:341-355.Crossref 310. Baraban JM, Wang RY, Aghajanian GK: Reserpine suppression of dorsal raphe neuronal firing: Mediation by adrenrgic system . Eur J Pharmacol 1978;52:27-36.Crossref 311. Baraban JM, Aghajanian GK: Suppression of firing activity of 5-HT neurons in the dorsal raphe by α-adrenoceptor antagonists . Neuropharmacology 1980;19:355-363.Crossref 312. Zis AP, Goodwin FK: Novel antidepressants and the biogenic amine hypothesis of depression: The case for iprindole and mianserin . Arch Gen Psychiatry 1979;36:1097-1107.Crossref 313. Brunel S, de Montigny C: Diurnal variation in the responsiveness of hippocampal pyramidal neurons to serotonin . Neurosci Abstr 1980;6:833. 314. Wehr TA, Muscettola G, Goodwin FK: Urinary 3-methoxy-4-hydroxyphenylglycol circadian rhythm: Early timing (phase-advance) in manicdepressives compared with normal subjects . Arch Gen Psychiatry 1980;37:257-263.Crossref 315. Pflug B, Erikson R, Johnsson A: Depression and daily temperature: A long-term study . Acta Psychiatr Scand 1978;54:254-266.Crossref 316. Wehr TA, Wirz-Justice A, Goodwin FK, et al: Phase advance of the sleep-wake cycle as an antidepressant . Science 1979;206:710-713.Crossref 317. Foster FG, Kupfer DJ: Psychomotor activity as a correlate of depression and sleep in acutely disturbed psychiatric patients . Am J Psychiatry 1975;132:928-931. 318. Halbreich U, Grunhaus L, Ben-David M: Twenty-four-hour rhythm of prolactin in depressive patients . Arch Gen Psychiatry 1979;36:1183-1186.Crossref 319. Nelson JC, Charney DS: The symptoms of major depressive illness . Am J Psychiatry 1981;138:1-13.Crossref 320. Leckman JF, Maas JW, Redmond DE, et al: Effects of oral clonidine on plasma 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) in man: preliminary report . Life Sci 1980;26:2179-2185.Crossref 321. Paul SM, Crews FM: Rapid desensitization of cerebral cortical β-adrenergic receptors induced by desmethylimipramine and phenoxybenzamine . Eur J Pharmacol 1980;62:349-350.Crossref 322. De Montigny C, Grunberg F, Mayer A, et al: Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders . Br J Psychiatry 1981;138:252-256.Crossref 323. Prange AJ, Wilson JC, Wabon AM, et al: Enhancement of imipramine antidepressant activity by thyroid hormone . Am J Psychiatry 1969;126:457-469. 324. Prange AJ, Wilson IC, Knox A, et al: Enhancement of imipramine by thyroid stimulating hormone: Clinical and theoretical implications . Am J Psychiatry 1970;127:191-199. 325. Earle BV: Thyroid hormone and tricyclic antidepressants in resistant depressions . Am J Psychiatry 1970;126:1667-1669. 326. Wheatley D: Potentiation of amitriptyline by thyroid hormone . Arch Gen Psychiatry 1972;26:229-233.Crossref 327. Coppen A, Whybrow PC, Noguera R, et al: The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine . Arch Gen Psychiatry 1972;26:234-241.Crossref 328. Feighner JP, King LJ, Schuckit MA, et al: Hormonal potentiation of imipramine and ECT in primary depression . Am J Psychiatry 1972;128:1230-1238. 329. Prange AJ Jr, in discussion, Feighner JP, King LJ, Schuckit MA, et al: Hormonal potentiation of imipramine and ECT in primary depression . Am J Psychiatry 1972;128:1230-1238. 330. Ogura C, Okuma T, Uchida Y, et al: Combined thyroid (triiodothyronine)-tricyclic antidepressant treatment in depressive states . Folia Psychiatr Neurol Jpn 1974;28:179-186. 331. Karlberg BE, Kjellman BF, Kagedal B: Treatment of endogenous depression with oral thyrotropin releasing hormone and amitriptyline . Acta Psychiatr Scand 1978;58:389-400.Crossref 332. Grob G, Brodde OE, Schumann HJ: Regulation of α1-adrenoceptors in the cerebral cortex of the rat by thyroid hormones . Naunyn Schmiedebergs Arch Pharmacol 1981;316:45-50.Crossref 333. Strombom U, Svensson TH, Jackson DM, et al: Hyperthroidism: Specifically increased response to central NA-(α-) receptor stimulation and generally increased monoamine turnover in brain . J Neural Transm 1977;41:73-92.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of General Psychiatry American Medical Association

Receptor Sensitivity and the Mechanism of Action of Antidepressant Treatment: Implications for the Etiology and Therapy of Depression

Download PDF
21 pages

Loading next page...
 
/lp/american-medical-association/receptor-sensitivity-and-the-mechanism-of-action-of-antidepressant-O0teWwkROA

References (340)

Publisher
American Medical Association
Copyright
Copyright © 1981 American Medical Association. All Rights Reserved.
ISSN
0003-990X
eISSN
1598-3636
DOI
10.1001/archpsyc.1981.01780350094011
Publisher site
See Article on Publisher Site

Abstract

Abstract • Considerable evidence suggests that the acute effects of antidepressant treatments on brain norepinephrine (NE) and serotonin (5-HT) systems cannot account fully for their delayed therapeutic action. This review evaluates the effects of long-term antidepressant treatment on biogenic amine metabolism and on various indexes of presynaptic and postsynaptic receptor function. In contrast to variable effects on NE and 5-HT turnover and on presynaptic receptor sensitivity, almost all long-term antidepressant treatments produce consistent alterations in a number of measures of postsynaptic amine receptor sensitivity. Longterm treatment has been found to reduce β-adrenergic sensitivity while enhancing responses to serotonergic and α-adrenergic stimulation, suggesting that modulation of receptor sensitivity may be a mechanism of action common to tricyclic antidepressants, "atypical" antidepressants, monoamine oxidase inhibitors, and electroconvulsive therapy. These findings provide support for hypotheses of amine receptor abnormalities in depression and indicate the need for expanded studies of amine receptor function in patients. References 1. References 31, 40, 66, 67, 69, 70, 72-74. 2. References 127-130, 136, 137, 142, 145, 154, 164-166. 3. References 167-175, 177, 178, 180, 181, 185, 187-189, 191, 195-204. 4. References 186, 209, 210, 213-215, 218-228. 5. Schildkraut JJ: The catecholamine hypothesis of affective disorders: A review of supporting evidence . Am J Psychiatry 1965;122:509-522. 6. Bunney WE Jr, Davis JM: Norepinephrine in depressive reactions: A review . Arch Gen Psychiatry 1965;13:483-494.Crossref 7. Maas JW: Biogenic amines and depression: Biochemical and pharmacological separation of two types of depression . Arch Gen Psychiatry 1975;32:1357-1361.Crossref 8. Sulser F, Vetulani J, Mobley PL: Mode of action of antidepressant drugs . Biochem Pharmacol 1978;27:257-261.Crossref 9. Rosloff BN, Davis JM: Effect of iprindole on norepinephrine turnover and transport . Psychopharmacologia 1974;40:53-64.Crossref 10. Gluckman MI, Baum T: The pharmacology of iprindole, a new antidepressant . Psychopharmacologia 1969;15:169-185. 11. Leonard BE: Some effects of a new tetracyclic antidepressant compound, Org GB94, on the metabolism of monoamines in the rat brain . Psychopharmacology 1974;36:221-236.Crossref 12. Goodlet F, Mireylees SE, Sugrue MF: Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines . Br J Pharmacol 1977;61:307-313.Crossref 13. Post RM, Kopin J, Goodwin FK: The effects of cocaine on depressed patients . Am J Psychiatry 1974;131:511-517. 14. Overall JE, Hollister LE, Pokorny AD, et al: Drug therapy in depressions: Controlled evaluation of imipramine, isocarboxazid, dextroamphetamine, amobarbital, and placebo . Clin Pharmacol Ther 1962;3:16-22. 15. Ghose K, Gupta R, Coppen A, et al: Antidepressant evaluation and the pharmacological actions of FG-4963 in depressive patients . Eur J Pharmacol 1977;42:31-37.Crossref 16. Iversen LL, Mackay AVP: Pharmacodynamics of antidepressants and antimanic drugs , in Paykel ES, Coppen A (eds): Psychopharmacology of Affective Disorders . New York, Oxford University Press Inc, 1979, pp 60-90. 17. Oswald I, Brezinova V, Dunleavy DLF: On the slowness of action of tricyclic antidepressant drugs . Br J Psychiatry 1972;120:673-677.Crossref 18. Klein DV, Gittelman R, Quitkin F, et al: Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children , ed 2. Baltimore, Williams & Wilkins Co, 1980. 19. Sugrue MF: Chronic antidepressant administration and adaptive changes in central monoaminergic systems , in Enna SJ, Malick JB, Richelson E (eds): Antidepressants: Neurochemical, Behavioral, and Clinical Perspectives . New York, Raven Press, to be published. 20. Roffman M, Kling MA, Cassens G, et al: The effects of acute and chronic administration of tricyclic antidepressants on MHPG-SO, in rat brain . Psychopharmacol Commun 1977;1:195-206. 21. Bareggi SR, Markey K, Genovese E: Effects of single and multiple doses of desipramine (DMI) on endogenous levels of 3-methoxy-4-hydroxyphenylglycol-sulfate (MOPEG-SO4) in rat brain . Eur J Pharmacol 1978;50:301-306.Crossref 22. Carlsson A, Lindqvist M: Effects of antidepressant agents on the synthesis of brain monoamines . J Neural Transm 1978;43:73-91.Crossref 23. Nielsen M: The influence of desipramine and amitriptyline on the accumulation of 3H-noradrenaline and its two major metabolites formed from 3H-tyrosine in the rat brain . J Pharm Pharmacol 1975;27:206-208.Crossref 24. Nielsen M, Braestrup C: Desipramine and some other antidepressant drugs decrease the major norepinephrine metabolite 3,4-dihydroxyphenylglycolsulphate in the rat brain . Naunyn Schmiedebergs Arch Pharmacol 1977;300:93-99.Crossref 25. Schildkraut JJ, Roffman M, Orsulak PJ, et al: Effects of short- and long-term administration of tricyclic antidepressants and lithium on norepinephrine turnover in brain . Pharmakopsychiatr Neuropsychopharmakol 1976;9:193-202.Crossref 26. Tang SW, Helmeste DM, Stancer HC: The effect of acute and chronic desipramine and amitriptyline treatment on rat brain total 3-methoxy4-hydroxyphenylglycol . Naunyn Schmiedebergs Arch Pharmacol 1978; 305:207-211.Crossref 27. Nielsen M, Eplov L, Scheel-Kruger J: The effect of amitriptyline, desipramine and imipramine on the in vivo brain synthesis of 3H-noradrenaline from 3H-l-dopa in the rat . Psychopharmacologia 1975;41:249-254.Crossref 28. Nyback HV, Walters JR, Aghajanian GK, et al: Tricyclic antidepressants: Effects on the firing rate of brain noradrenergic neurons . Eur J Pharmacol 1975;32:302-312.Crossref 29. Scuvee-Moreau JJ, Dresse AE: Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphe neurons of the rat . Eur J Pharmacol 1979;57:219-225.Crossref 30. Langer SZ, Briley MS, Raisman R: Regulation of neurotransmission through presynaptic receptors and other mechanisms: Possible clinical relevance and therapeutic potential , in Pepau G, Kuhar MJ, Enna SJ (eds): Receptors for Neurotransmitters and Peptides . New York, Raven Press, 1980, pp 203-206. 31. Cedarbaum JM, Aghajanian GK: Catecholamine receptors on locus coeruleus neurons: Pharmacological characterization . Eur J Pharmacol 1977;44:375-385.Crossref 32. Neff NM, Costa E: Effect of tricyclic antidepressants and chlorpromazine on brain catecholamine synthesis , in Garattini S, Dukes MNG (eds): Antidepressant Drugs . Amsterdam, Excerpta Medica, 1967, pp 28-34. 33. Pugsley TA, Lippmann W: Effect of acute and chronic treatment of tandamine, a new heterocyclic antidepressant, on biogenic amine metabolism and related activities . Naunyn Schmiedebergs Arch Pharmacol 1979;308:239-247.Crossref 34. Tang SW, Helmeste DM, Stancer HC: Interaction of antidepressants with clonidine on rat brain total 3-methoxy-4-hydroxyphenylglycol . Can J Physiol Pharmacol 1979;57:435-437.Crossref 35. Sugrue MF: Changes in rat brain monoamine turnover following chronic antidepressant administration . Life Sci 1980;26:423-429.Crossref 36. McMillen BA, Warnack W, German DC, et al: Effects of chronic desipramine treatment on rat brain noradrenergic responses to α-adrenergic drugs . Eur J Pharmacol 1980;61:239-246.Crossref 37. Segal DS, Kuczenski R, Mandell AJ: Theoretical implications of drug-induced adaptive regulation for a biogenic amine hypothesis of affective disorder . Biol Psychiatry 1974;9:147-159. 38. Nielsen M, Braestrup C: Chronic treatment with desipramine caused a sustained decrease of 3,4-dihydroxyphenylglycolsulphate and total 3-methoxy-4-hydroxyphenylglycol in the rat brain . Naunyn Schmiedebergs Arch Pharmacol 1977;300:87-92.Crossref 39. Rosloff BN, Davis JM: Decrease in brain NE turnover after chronic DMI treatment: No effect with iprindole . Psychopharmacology 1978;56:335-341.Crossref 40. Crews FT, Smith CB: Presynaptic alpha-receptor subsensitivity after long-term antidepressant treatment . Science 1978;202:322-324.Crossref 41. Harper B, Hughes IE: Presynaptic α-adrenoceptor blocking properties among tri- and tetra-cyclic antidepressant drugs . Br J Pharmacol 1979;67:511-517.Crossref 42. Huang YH, Maas JW, Hu G: The time course of noradrenergic preand post-synaptic activity during chronic desipramine treatment . Eur J Pharmacol 1980;68:41-47.Crossref 43. Schildkraut JJ, Winokur A, Draskoczy PR, et al: Changes in norepinephrine turnover in rat brain during chronic administration of imipramine and protriptyline: A possible explanation for the delay in onset of clinical antidepressant effects . Am J Psychiatry 1971;127:72-79. 44. Friedman E, Shopsin B, Goldstein M, et al: Interactions of imipramine and synthesis inhibitors of biogenic amines . J Pharm Pharmacol 1974;26:995-997.Crossref 45. Mogilnicka E, Klimek V: Effect of chronic administration of antidepressant drugs on the noradrenaline disappearance induced by FLA-63 in the rat brain . Pol J Pharmacol Pharm 1979;31:139-147. 46. Schildkraut JJ, Winokur A, Applegate CW: Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine . Science 1970;168:867-869.Crossref 47. Svensson TH, Usdin T: Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: α-Receptor mediation . Science 1978;202:1089-1091.Crossref 48. Svensson TH: Effect of chronic treatment with tricyclic antidepressant drugs on identified brain noradrenergic and serotonergic neurons . Acta Psychiatr Scand 1980;61( (suppl 280) ):121-131. 49. Brogden RN, Heel RC, Speight TM: Mianserin: A review of its pharmacological properties and therapeutic efficacy in depressive illness . Drugs 1978;16:273-301.Crossref 50. Peet M, Bahagel H: Mianserin: A decade of scientific development . Br J Pharmacol 1978;5:5S-9S. 51. Leonard BE: Some effects of mianserin on monoamine metabolism in the rat brain . Br J Pharmacol 1978;5:11S-12S. 52. Coppen A, Ghose K, Swade C, et al: Effect of mianserin hydrochloride on peripheral uptake mechanisms for noradrenaline and 5-hydroxytryptamine in man . Br J Pharmacol 1978;5:13S-17S. 53. Baumann PA, Matre L: Blockade of presynaptic α-receptors and of amine uptake in the rat brain by the antidepressant mianserin . Naunyn Schmiedebergs Arch Pharmacol 1977;300:31-37.Crossref 54. Fludder JM, Leonard BE: Interaction between mianserin and clonidine in the rat brain in vivo . Commun Psychopharmacol 1978;2:487-490. 55. Fludder JM, Leonard BE: Chronic effects of mianserin on noradrenaline metabolism in the rat brain: Evidence for a pre-synaptic α-adrenolytic action in vivo . Psychopharmacology 1979;64:329-332.Crossref 56. Sugrue MF: Chronic antidepressants and rat brain monoamine adaptive changes . Trans Am Soc Neurochem 1980;11:208. 57. Robinson DS, Campbell IC, Walker M, et al: Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain . Neuropharmacology 1979;18:771-776.Crossref 58. Campbell IC, Robinson DS, Lovenberg W, et al: The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain . J Neurochem 1979;32:49-55.Crossref 59. Campbell IC, Colburn RW, Walker RW, et al: Norepinephrine and serotonin metabolism in the rat brain: Effects of chronic phenelzine administration , in Deniker P, Radouco-Thomas C, Villeneura A (eds): Neuro-psychopharmacology . New York, Pergamon Press, 1978, pp 629-640. 60. Campbell IC, Marshall EF: Effects of chronic regimens of phenelzine, tranylcypromine, and imipramine on rat brain norepinephrine and serotonin . J Pharmacol 1974;5( (suppl 2) ):14. 61. Musacchio JM, Julou L, Kety SS, et al: Increase in rat brain tyrosine hydroxylase activity produced by electroconvulsive shock . Proc Natl Acad Sci USA 1969;63:1117-1119.Crossref 62. Modigh K: Long-term effects on electroconvulsive shock therapy on synthesis turnover and uptake of brain monoamines . Psychopharmacology 1976;49:179-185.Crossref 63. Schildkraut JJ, Draskoczy PR, Sun Lo P: Norepinephrine pools in rat brain: Differences in turnover rates and pathways of metabolism . Science 1971;172:587-589.Crossref 64. Kety SS, Javoy F, Thierry AM, et al: A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat . Proc Natl Acad Sci USA 1969;58:1249-1254.Crossref 65. Ladisch W, Steinhauff N, Matussek N: Chronic administration of electroconvulsive shock and norepinephrine metabolism in the rat brain . Psychopharmacologia 1969;15:296-304.Crossref 66. Ebert MH, Baldessarini RJ, Lipinski JF, et al: Effects of electroconvulsive seizures on amine metabolism in the rat brain . Arch Gen Psychiatry 1973;29:397-401.Crossref 67. Aghajanian GK: Feedback regulation of central monoaminergic neurons: Evidence from single cell recording studies , in Youdim MBH, Lovenberg W, Sharman DR, et al (eds): Essays in Neurochemistry and Neuropharmacology . New York, John Wiley & Sons Inc, 1978, pp 1-31. 68. Corrodi H, Fuxe K: Decreased turnover in central 5-HT nerve terminals induced by antidepressant drugs of the imipramine type . Eur J Pharmacol 1969;7:56-59Crossref 69. Goodlet I, Sugrue MF: Effect of acutely administered analgesic drugs on rat brain serotonin turnover . Eur J Pharmacol 1974;29:241-248.Crossref 70. Marco EJ, Meek JL: The effects of antidepressants on serotonin turnover in discrete regions of rat brain . Naunyn Schmiedebergs Arch Pharmacol 1979;306:75-79.Crossref 71. Meek J, Werdinius B: Hydroxytryptamine turnover decreased by the antidepressant drug chlorimipramine . J Pharm Pharmacol 1970;22:141-143.Crossref 72. Modigh K: Effect of chlorimipramine on the rate of tryptophan hydroxylation in the intact and transected spinal cord . J Pharm Pharmacol 1973;25:926-928.Crossref 73. Leonard BE, Kafoe WF: A comparison of the acute and chronic effects of four antidepressant drugs on the turnover of serotonin, dopamine and noradrenaline in the rat brain . Biochem Pharmacol 1976;25:1939-1942.Crossref 74. Van Wijk M, Meisch JJ, Korf J: Metabolism of 5-hydroxytryptamine and levels of tricyclic antidepressant drugs in rat brain after acute and chronic treatment . Psychopharmacology 1977;55:217-223.Crossref 75. Kafoe WF, De Ridder JJ, Leonard BE: The effect of a tetracyclic antidepressant compound, Org GB94, on the turnover of biogenic amines in rat brain . Biochem Pharmacol 1976;25:2455-2460.Crossref 76. Alpers HS, Himwich HE: The effects of chronic imipramine administration on rat brain levels of serotonin, 5-hydroxyindoleacetic acid, norepi nephrine and dopamine . Pharmacol Exp Ther 1972;180:531-538. 77. Svensson TH: Attenuated feedback inhibition of brain serotonin synthesis following chronic administration of imipramine . Naunyn Schmiedebergs Arch Pharmacol 1978;302:115-118.Crossref 78. Sherman A: Time course of the effects of antidepressants on serotonin in rat neocortex . Commun Psychopharmacol 1979;3:1-5. 79. Sanghvi I, Gershon S: Effect of acute and chronic iprindole on serotonin turnover in mouse brain . Biochem Pharmacol 1975;24:2103-2104.Crossref 80. Fuxe K, Ogren SO, Agnati LF: The effects of chronic treatment with the 5-hydroxytryptamine uptake blocker zimelidine on central 5-hydroxy tryptamine mechanisms: Evidence for the induction of a low affinity binding site for 5-hydroxytryptamine . Neurosci Lett 1979;13:307-312.Crossref 81. Engel J, Hanson LCF, Roos B-E: Effect of electroshock on 5-HT metabolism in rat brain . Psychopharmacologia 1971;20:197-200.Crossref 82. Shields PJ: Effects of electroconvulsive shock on the metabolism of 5-hydroxytryptamine in rat brain . J Pharm Pharmacol 1972;24:919-921.Crossref 83. Hinsley RK, Norton JA, Aprison MH: Serotonin, norepinephrine, and 3,4,dihydroxyphenylethylamine in rat brain parts following electroconvul sive shock . J Psychiatr Res 1968;6:143-152.Crossref 84. Kato L, Gözsy B, Roy RB, et al: Histamine serotonin epinephrine and norepinephrine in rat brain, following convulsions . Int J Neuropsychiatry 1967;3:46-51. 85. Cooper AJ, Moir ATP, Goldberg HC: Effect of electroconvulsive shock on the cerebral metabolism of dopamine and 5-hydroxytryptamine . J Pharm Pharmacol 1968;20:729-730.Crossref 86. Feighner JP, Lao L, King LJ, et al: Brain serotonin and norepineph rine after convulsions and reserpine . J Neurochem 1972;19:905-907.Crossref 87. Tagliamonte A, Tagliamonte P, Di Chiara G, et al: Increase in brain tryptophan by electroconvulsive shock in rats . J Neurochem 1972;19:1509-1512.Crossref 88. Garattini S, Kato R, Lamesta L, et al: Electroshock, brain serotonin, and barbiturate narcosis . Experientia 1960;16:156-157.Crossref 89. Maas JW, Fawcett JA, Dekirmenjian H: Catecholamine metabolism, depressive illness, and drug response . Arch Gen Psychiatry 1972;26:252-262.Crossref 90. Goodwin FK, Post RM, Sack RL: Clinical evidence for neurochemical adaptation to psychotropic drugs , in Mandell AJ (ed): Neurobiological Mechanisms of Adaptation and Behavior . New York, Raven Press, 1975, pp 33-46. 91. Beckmann H, Goodwin FK: Antidepressant response to tricyclics and urinary MHPG in unipolar patients: Clinical response to imipramine and amitriptyline . Arch Gen Psychiatry 1975;32:17-21.Crossref 92. Perry GF, Fitzsimmons B, Shapiro L, et al: Clinical study of mianser in, imipramine, and placebo in depression: Blood level and MHPG correlations . Br J Clin Pharmacol 1978;5:35S-41S.Crossref 93. Cobbin DM, Requin-Blow B, Williams LR, et al: Urinary MHPG levels and tricyclic antidepressant drug selection: A preliminary communication on improved drug selection in clinical practice . Arch Gen Psychiatry 1979;36:1111-1115.Crossref 94. Halaris A, DeMet EM: Studies of norepinephrine metabolism in manic and depressive states , in Usdin E, Kopin IJ, Barchas J (eds): Catecholamines: Basic and Clinical Frontiers . New York, Pergamon Press, 1978, pp 1866-1868. 95. Veith RC, Bielski RJ, Friedel RO, et al: Urinary 3-methoxy-4-hydroxy-phenylglycol levels in depressed out-patients. Read before the 133rd annual meeting of the American Psychiatric Association, San Francisco, May 1980. 96. Beckmann H, Murphy DL: Phenelzine in depressed patients: Effects on urinary MHPG excretion in relation to clinical response . Neuropsycho-biology 1977;3:49-55.Crossref 97. Rosenbaum AH, Schatzberg AF, Maruta T, et al: MHPG as a predictor of antidepressant response to imipramine and maprotiline . Am J Psychiatry 1980;137:1090-1092. 98. Schildkraut J: Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: Preliminary findings . Am J Psychiatry 1973;130:695-699. 99. Sacchetti E, Smeraldi E, Cagnasso P, et al: MHPG, amitriptyline, and affective disorders: A longitudinal study . Int Pharmacopsychiatry 1976;11:157-162. 100. Modai I, Apter A, Golomb M, et al: Response to amitriptyline and urinary MHPG in bipolar depressed patients . Neuropsychobiology 1979;5:181-184.Crossref 101. Sacchetti E, Aliaria E, Negri F, et al: 3-Methoxy-4-hydroxyphenylgly-col and primary depression: Clinical and pharmacological considerations . Biol Psychiatry 1979;14:473-484. 102. Coppen A, Rama Rao VA, Ruthren CRJ, et al: Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitripty line in depressive illness . Psychopharmacology 1979;64:95-97.Crossref 103. Spiker DG, Edwards D, Hanin I, et al: Urinary MHPG and clinical response to amitriptyline in depressed patients . Am J Psychiatry 1980;137:1183-1187. 104. Hollister LE, Davis KL, Berger PA: Subtypes of depression based on excretion of MHPG and response to nortriptyline . Arch Gen Psychiatry 1980;37:1107-1110.Crossref 105. Siwers B, Ringberger VA, Tuck R, et al: Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients . Clin Pharmacol Ther 1976;21:194-200. 106. Bertilsson L, Asberg M, Thoren P: Differential effect of chlorimip ramine and nortriptyline on cerebrospinal fluid metabolites of serotonin and noradrenaline in depression . Eur J Clin Pharmacol 1976;21:194-200. 107. Asberg M, Ringberger VA, Sjoqvist F, et al: Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine . Clin Pharmacol Ther 1975;21:201-207. 108. Traskman L, Asberg M, Bertilsson L, et al: Plasma levels of chlor imipramine and its desmethyl metabolite during treatment of depression . Clin Pharmacol Ther 1979;26:600-610. 109. Post RM, Goodwin FK: Effects of amitriptyline and imipramine on amine metabolites in the cerebrospinal fluid of depressed patients . Arch Gen Psychiatry 1974;30:234-239.Crossref 110. Papeschi R, McClure DJ: Homovanillic and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients . Arch Gen Psychiatry 1971;25:354-358.Crossref 111. Bowers MB: Amitriptyline in man: Decreased formation of central 5-hydroxyindoleacetic acid . Clin Pharmacol Ther 1974;15:167-170. 112. Asberg M, Bertilsson L, Tuck D, et al: Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline . Clin Pharmacol Ther 1972;14:277-286. 113. Kupfer DJ, Bowers MB Jr: REM sleep and central monoamine oxidase inhibition . Psychopharmacologia 1972;27:182-190.Crossref 114. Bowers MB Jr, Kupfer DJ: Central monoamine oxidase inhibition and REM sleep . Brain Res 1971;35:561-564.Crossref 115. Nordin G, Ottosson JO, Roos BE: Influence of convulsive therapy on 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid in endogenous depression . Psychopharmacologia 1971;20:315-320.Crossref 116. Ashcroft GW, Crawford TBB, Eccleston D, et al: 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases . Lancet 1966;2:1049-1052.Crossref 117. Harnryd C, Bjerkenstedt L, Grimm VE, et al: Induction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment . Psychopharmacology 1979;64:131-134.Crossref 118. Abrams R, Essman WB, Taylor MA, et al: Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebro spinal fluid of depressed patients before and after ECT . Biol Psychiatry 1976;11:85-90. 119. Bowers MB, Heninger GR, Gerbode FA: Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients . Int J Neuropharmacol 1969;8:255-262.Crossref 120. Asberg M, Bertilsson L, Thoren P, et al: CSF monoamine metabolites in depressive illness , in Garattini S (chair): Depressive Disorders . Stuttgart, Germany, Friedrich-Karl Sehattauer Verlag, 1978, pp 293-305. 121. Van Praag HM: Biogenic amines: New evidence of serotonin-deficient depressions , in Garattini S (chair): Depressive Disorders . Stutt gart, Germany, Friedrich-Karl Sehattauer Verlag, 1978, pp 9-16. 122. Bertilsson L, Asberg M, Mellstrom B, et al: Factors determining drug effects in depressed patients: Studies of nortriptyline and chlorimipramine , in Garattini S (chair): Depressive Disorders . Stuttgart, Germany, Friedrich-Karl Sehattauer Verlag, 1978, pp 281-292. 123. Greengard P: Possible role for cyclic nucleotides and phosphorylated membrane proteins in postsynaptic actions of neurotransmitters . Nature 1976;260:101-108.Crossref 124. Sulser F: New perspectives on the mode of action of antidepressant drugs . Trends Pharmacol Sci 1979;1:92-94.Crossref 125. Baudry M, Martres MP, Schwartz JC: Modulation in the sensitivity of noradrenergic receptors in the CNS studied by the responsiveness of the cyclic AMP system . Brain Res 1976;116:111-124.Crossref 126. Schwartz JC, Costentin J, Martres MP, et al: Modulation of receptor mechanisms in the CNS: Hyper- and hypo-sensitivity to catecholamines . Neuropharmacology 1978;17:665-685.Crossref 127. Iversen LL: Catecholamine-sensitive adenylate cyclases in nervous tissues . J Neurochem 1977;29:5-12.Crossref 128. Kalisker A, Rutledge CO, Perkins JP: Effect of nerve degeneration by 6-hydroxydopamine on catecholamine-stimulated adenosine 3',5'-monophosphate formation in rat cerebral cortex . Mol Pharmacol 1973;9:619-629. 129. Blumberg JB, Vetulani J, Stawarz RJ, et al: The noradrenergic cyclic AMP generating system in the limbic forebrain: Pharmacological characterization in vitro and possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics . Eur J Pharmacol 1976;37:357-366.Crossref 130. Palmer GC, Robinson GA, Sulser F: Modification by psychotropic drugs of the cyclic adenosine monophosphate response to norepinephrine in rat brain . Biochem Pharmacol 1971;20:236-239.Crossref 131. Vetulani J, Stawarz RJ, Dingell JV, et al: A possible common mechanism of action of antidepressant treatments . Naunyn Schmiedebergs Arch Pharmacol 1976;293:109-114.Crossref 132. Mishra R, Sulser F: Role of serotonin reuptake inhibition in the development of subsensitivity of the norepinephrine (NE) receptor coupled adenylate cyclase system . Commun Psychopharmacol 1978;2:365-370. 133. Mishra R, Janowsky A, Sulser F: Action of mianserin and zimelidine on the norepinephrine receptor coupled adenylate cyclase system in brain: Subsensitivity without reduction in β-adrenergic receptor binding . Neuropharmacology 1980;19:983-987.Crossref 134. Wolfe BB, Harden TK, Sporn JR, et al: Presynaptic modulation of beta-adrenergic receptors in rat cerebral cortex after treatment with antidepressants . J Pharmacol Exp Ther 1978;207:446-457. 135. Carlsson A, Corrodi H, Fuxe K, et al: Effects of some antidepressants on the depletion of intraneuronal brain catecholamine stores caused by 4-α-dimethylmetatyramine . Eur J Pharmacol 1969;5:367-373.Crossref 136. Horn AS: The interaction of tricyclic antidepressants with biogenic amine uptake systems in the central nervous system . Postgrad Med J 1976;52( (suppl 3) ):25-32. 137. Glowinski J, Axelrod J: Inhibition of uptake of tritiated noradrenaline in the intact rat brain by imipramine and structurally related compounds . Nature 1964;204:1318-1319.Crossref 138. Ross SB, Renyi A: Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents . Eur J Pharmacol 1967;2:181-186.Crossref 139. Nahorski SR: Altered responsiveness of cerebral β-adrenoreceptors assessed by adenosine cyclic 3',5'-monophosphate formation and 3H-propranolol binding . Mol Pharmacol 1977;13:679-689. 140. Vetulani J, Sulser F: Action of various antidepressant treatments reduce reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain . Nature 1975;257:495-496.Crossref 141. Vetulani J, Stawarz RJ, Sulser F: Adaptive mechanisms of the noradrenergic cyclic AMP generating system in the limbic forebrain of the rat: Adaptation to persistent changes in the availability of norepinephrine (NE) . J Neurochem 1976;27:661-666.Crossref 142. Dolphin A, Sawaya CB, Jenner P, et al: Behavioural and biochemical effects of chronic reduction of cerebral noradrenaline receptor stimulation . Naunyn Schmiedebergs Arch Pharmacol 1977;299:167-173.Crossref 143. Ross SB, Renyi AL, Ogren SO: A comparison of the inhibiting activities of iprindole and imipramine on the uptake of 5-hydroxytryptamine and noradrenaline in brain slices . Life Sci 1971;10:1267-1277.Crossref 144. Georgotas A, Mann J, Bush D, et al: A clinical trial of zimelidine in depression . Commun Psychopharmacol 1980;4:71-77. 145. Aberg A, Holmburg G: Preliminary clinical test of zimelidine, a new 5-HT uptake inhibitor . Acta Psychiatr Scand 1979;59:45-58.Crossref 146. Schmidt MJ, Thornberry JF: Norepinephrine-stimulated cyclic AMP accumulation in brain slices in vitro after serotonin depletion or chronic administration of selective amine reuptake inhibitors . Arch Int Pharmacodyn Ther 1977;229:42-51. 147. Schultz J, Daly JW: Accumulation of cyclic adenosine 3',5'-monophosphate in cerebral cortical slices from rat and mouse: Stimulatory effect of aand β-adrenergic agents and adenosine . J Neurochem 1973;21:1319-1326.Crossref 148. Mobley PL, Sulser F: Norepinephrine stimulated cyclic AMP accumulation in rat limbic forebrain slices: Partial mediation by a subpopulation of receptors with neither α nor β characteristics . Eur J Pharmacol 1979;60:221-227.Crossref 149. Gillespie DD, Manier DH, Sulser F: Electroconvulsive treatment: Rapid subsensitivity of the norepinephrine receptor coupled adenylate cyclase system in brain linked to down regulation of β-adrenergic receptors . Commun Psychopharmacol 1979;3:191-194. 150. Jones DJ, McKenna LF: Cyclic AMP formation in rat spinal cord tissue slices . Neuropharmacology 1980;19:669-674.Crossref 151. Skolnick P, Daly JW: Stimulation of adenosine 3',5'-monophosphate formation in rat cerebral cortical slices by methoxamine: Interaction with an alpha adrenergic receptor . J Pharmacol Exp Ther 1975;193:549-558. 152. Daly JW, Padgett W, Nimitkitpaisan Y, et al: Fluoronorepinephrines: Specific agonists for the activation of alpha and beta adrenergicsensitive cyclic AMP-generating systems in brain slices . J Pharmacol Exp Ther 1980;212:382-389. 153. Palmer GC, Robison GA, Manian AA, et al: Modification by psychotropic drugs of the cyclic AMP response to norepinephrine in the rat brain in vitro . Psychopharmacologia 1972;23:201-211.Crossref 154. Kakiuchi S, Rall TW: The influence of chemical agents on the accumulation of adenosine 3',5'-phosphate in slices of rabbit cerebellum . Mol Pharmacol 1968;4:367-378. 155. Palmer GC, Sulser F, Robison GA: Effects of neurohumoral and adrenergi, [ill] on cyclic AMP levels in various areas of the rat brain in vitro . Neuropharmacology 1973;12:327-337.Crossref 156. Huang M, Ho AKS, Daly JR: Accumulation of adenosine cyclic 3',5'-monophosphate in rat cerebral cortical slices: Stimulatory effect of alpha and beta adrenergic agents after treatment with 6-hydroxydopamine, 2,3,5,-trihydroxyphenethylamine, and dihydroxytryptamine . Mol Pharmacol 1973;9:711-717. 157. Sattin A: Increased activity of adenosine-stimulated adenylate cyclase in cortex following electroconvulsive seizures (ECT) . Neurosci Abstr 1980;6:720. 158. Schultz J: Psychoactive drug effects on a system which generates cyclic AMP in brain . Nature 1976;261:417-418.Crossref 159. Raskin A, Schulterbrandt JG, Reatig N, et al: Differential response to chlorpromazine, imipramine, and placebo: A study of subgroups of hospitalized depressed patients . Arch Gen Psychiatry 1970;23:164-173.Crossref 160. Korf J, Sebens JB, Postema F: Cyclic AMP in the rat cerebral cortex after stimulation of the locus coeruleus: Decrease by antidepressant drugs . Eur J Pharmacol 1979;59:23-30.Crossref 161. Minneman KP, Quik M, Emson PC: Receptor-linked cyclic AMP systems in rat neostriatum: Differential localization revealed by kinic acid injection . Brain Res 1978;151:507-521.Crossref 162. Palmer GC, Wagner MR, Putnam RW: Neuronal localization of the enhanced adenylate cyclase responsiveness to catecholamines in rat cerebral cortex following reserpine injections . Neuropharmacology 1976;15:695-702.Crossref 163. Partington CR, Edwards MW, Daly JW: Regulation of cyclic AMP formation in brain tissue by alpha-adrenergic receptors: Requisite intermediacy of prostaglandins of the E series . Proc Natl Acad Sci USA 1980;77:3024-3028.Crossref 164. Bockaert J, Tassin JP, Thierry AM, et al: Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat: Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases . Brain Res 1977;122:71-86.Crossref 165. Dolphin A, Adrien J, Hamon M, et al: Identity of 3H-dihydroalprenolol binding sites and β-adrenergic receptors coupled with adenylate cyclase in the central nervous system: Pharmacological properties, distribution and adaptive responsiveness . Mol Pharmacol 1979;15:1-15. 166. Jones RSG: Noradrenaline sensitive adenylate cyclase in rat cerebral cortex: Effects of antidepressant drugs . Neuropharmacology 1978;17:771-774.Crossref 167. Türck M, Schocker WF, Fathy AM, et al: Adrenergic subsensitivity of a cell-free adenylate cyclase from rat brain after chronic imipramine treatment . Arch Pharm 1980;313:768-773.Crossref 168. Frazer A, Mendels J: Do tricyclic antidepressants enhance adrenergic transmission? Am J Psychiatry 1977;134:1040-1042. 169. Frazer A, Pandey G, Mendels J, et al: The effect of tri-iodothyronine in combination with imipramine on 3H-cyclic AMP production in slices of rat cerebral cortex . Neuropharmacology 1974;13:1131-1140.Crossref 170. Frazer A, Hess ME, Mendels J, et al: Influence of acute and chronic treatment with desmethylimipramine on catecholamine effects in the rat . J Pharmacol Exp Ther 1978;206:311-319. 171. Banerjee SP, Kung LS, Riggi SJ, et al: Development of β-adrenergic receptor subsensitivity by antidepressants . Nature 1977;268:455-456.Crossref 172. Vogel GW, Vogel F, McAbee RS, et al: Improvement of depression by REM sleep deprivation: New findings and a theory . Arch Gen Psychiatry 1980;37:247-253.Crossref 173. Mogilnicka E, Arbilla S, Depoortere H, et al: Rapid-eye-movement sleep deprivation decreases the density of 3H-dihydroalprenolol and 3H-imipramine binding sites in the rat cerebral cortex . Eur J Pharmacol 1980;65:289-292.Crossref 174. Bergstrom DA, Kellar KJ: Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment . J Pharmacol Exp Ther 1979;209:256-261. 175. Peroutka SJ, Snyder SH: Regulation of serotonin2 (5-HT2) receptors labeled with 3H-spiroperidol by chronic treatment with the antidepressant amitriptyline . J Pharmacol Exp Ther 1980;215:582-587. 176. Sellinger-Barnette MM, Mendels J, Frazer A: The effect of psychoactive drugs on beta-adrenergic receptor binding sites in rat brain . Neuropharmacology 1980;19:447-454.Crossref 177. Peroutka SJ, Snyder SH: Chronic antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding . Science 1980; 210:88-90.Crossref 178. Sellinger M, Sarai K, Frazer A, et al: Beta adrenergic receptor binding in rat cerebral cortex after repeated administration of psychotropic drugs . Fed Proc 1978;37:309. 179. Clements-Jewery S: The development of cortical β-adrenoceptor subsensitivity in the rat by chronic treatment with trazodone, doxepin, and mianserin . Neuropharmacology 1978;17:779-781.Crossref 180. Rehavi M, Ramot O, Yavetz B, et al: Amitriptyline: Long-term treatment elevates α-adrenergic and muscarinic receptor binding in mouse brain . Brain Res 1980;194:443-453.Crossref 181. Rosenblatt JE, Pert CB, Tallman JF, et al: The effect of imipramine and lithium on α- and β-receptor binding in rat brain . Brain Res 1979;160:186-191.Crossref 182. Tang SW, Seeman P: Effect of antidepressant drugs on serotonergic and adrenergic receptors . Naunyn Schmiedebergs Arch Pharmacol 1980;311:255-261.Crossref 183. U'Prichard DC, Greenberg DA, Sheehan PP, et al: Tricyclic antidepressants: Therapeutic properties and affinity for α-noradrenergic receptor binding sites in the brain . Science 1978;199:197-198.Crossref 184. Johnson RW, Reisine T, Spotnitz S, et al: Effects of desipramine and yohimbine on α2 and β-adrenoceptor sensitivity . Eur J Pharmacol 1980;67:123-127.Crossref 185. Reisine TD, U'Prichard DC, Wiech NL, et al: Effects of combined administration of amphetamine and iprindole on brain adrenergic receptors . Brain Res 1980;188:587-592.Crossref 186. Smith CB, Garcia-Sevilla JA, Hollingsworth PJ: Alpha-2 adrenoceptors in rat brain are decreased after long-term tricyclic antidepressant drug treatment . Brain Res 1981;210:413-418.Crossref 187. Vetulani J, Pik A, Nikitin K: The effect of chronic imipramine treatment of rats on 3H-clonidine binding in the brain . Prog Neuropsychopharmacol 1980;12( (suppl 1) ):349. 188. Campbell IC, Murphy DL, Gallager DW, et al: Neurotransmitterrelated adaptation in the central nervous system following chronic monoamine oxidase inhibition , in Singer TP, Von Korff RW, Murphy DL (eds): Monoamine Oxidase: Structure, Function, and Altered Functions . New York, Academic Press Inc, 1979, pp 517-530. 189. Fuxe K, Ogren S-O, Agnati LF: The effects of chronic treatment with the 5-hydroxytryptamine uptake blocker zimelidine on central 5hydroxytryptamine mechanisms: Evidence for the induction of a low affinity binding site for 5-hydroxytryptamine . Neurosci Lett 1979;13:307-312.Crossref 190. De Montigny C, Blier P, Caille G, et al: Pre- and postsynaptic effects of zimelidine and norzimelidine on the serotoninergic system: Single cell studies in the rat . Acta Psychiatr Scand 1981;63( (suppl 290) ):79-90.Crossref 191. Peroutka SJ, Snyder SH: Multiple serotonin receptors: Differential binding of 3H-5-hydroxytryptamine, 3H-lysergic acid diethylamide and 3H-spiroperidol . Mol Pharmacol 1979;16:687-699. 192. Tang SW, Seeman P, Kwan S: Effect of chronic tricyclic antidepressant treatment on serotonergic and histaminergic receptors . Neurosci Abstr 1980;6:861. 193. Blackshear MA, Steranka R, Sanders-Bush E: Serotonin receptor subtypes after chronic treatment with tricyclic antidepressant drugs . Neurosci Abstr 1980;6:860. 194. Mann E, Enna SJ: Neurochemical and behavioral correlates of antidepressant drug action . Neurosci Abstr 1980;6:800. 195. Kellar KJ, Cascio CS, Butler JA, et al: Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain . Eur J Pharmacol 1981;69:515-518.Crossref 196. Nielsen EB, Nielsen M, Ellison G, et al: Decreased spiroperidol and LSD binding in rat brain after continuous amphetamine . Eur J Pharmacol 1980;66:149-154.Crossref 197. Middlemiss JA, Carroll JA, Fisher RW, et al: Does 3H-spiroperidol label a 5-HT receptor in the frontal cortex of the rat? Eur J Pharmacol 1980;60:253-254.Crossref 198. Snyder SH, Yamamura HI: Antidepressants and the muscarinic acetylcholine receptor . Arch Gen Psychiatry 1977;34:236-239.Crossref 199. Maggi A, U'Prichard DC, Enna SJ: Differential effects of antidepressant treatment on brain monoaminergic receptors . Eur J Pharmacol 1980;61:91-98.Crossref 200. Savage DD, Frazer A, Mendels J: Differential effects of monoamine oxidase inhibitors and serotonin reuptake inhibitors on 3H-serotonin receptor binding in rat brain . Eur J Pharmacol 1979;58:87-88.Crossref 201. Wirz-Justice A, Krauchi K, Lichtsteiner M, et al: Is it possible to modify serotonin receptor sensitivity? Life Sci 1978;23:1249-1254.Crossref 202. Sarai K: Desmethylimipramine-induced decrease in β-adrenergic receptor binding in rat cerebral cortex . Biochem Pharmacol 1978;27:2179-2181.Crossref 203. Minneman KP, Wolfe BB, Dibner MD, et al: β1- And β2-adrenergic receptors in rat cerebral cortex are independently regulated . Science 1979204:866-868.Crossref 204. Schweitzer JW, Schwartz R, Friedhoff AJ: Intact presynaptic terminals required for beta-adrenergic receptor regulation by desipramine . J Neurochem 1979;33:377-379.Crossref 205. Wirz-Justice A, Kafka MS, Naber D, et al: Circadian rhythms in rat brain alpha- and beta-adrenergic receptors are modified by chronic imipramine . Life Sci 1980;27:341-347.Crossref 206. Segawa T, Mizuta T, Nomura Y: Modifications of central 5-hydroxytryptamine binding sites in synaptic membranes from rat brain after long-term administration of tricyclic antidepressants . Eur J Pharmacol 1979;58:75-83.Crossref 207. Bergstrom DA, Kellar KJ: Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain . Nature 1979;278:464-466.Crossref 208. Pandey GN, Heinze WJ, Brown BD, et al: Electroconvulsive shock treatment decreases β-adrenergic receptor sensitivity in rat brain . Nature 1979;280:234-235.Crossref 209. Aghajanian GK: Tricyclic antidepressants and single cell responses to serotonin and norepinephrine: A review of chronic studies , in Usdin E, Bunney WE, Davis JM (eds): Neuroreceptors: Basic and Clinical Aspects . New York, John Wiley & Sons Inc, 1981, pp 27-35. 210. Dillier N, Laszlo J, Muller B, et al: Activation of an inhibitory noradrenergic pathway projecting from the locus coeruleus to the cingulate cortex of the rat . Brain Res 1978;154:61-68.Crossref 211. Hoffer BJ, Siggins GR, Bloom FE: Studies on norepinephrinecontaining afferents to Purkinje cells of rat cerebellum: II. Sensitivity of Purkinje cells to norepinephrine and related substances administered by microiontophoresis . Brain Res 1971;25:523-534.Crossref 212. Segal M, Bloom FE: The action of norepinephrine in the rat hippocampus: I. Iontophoretic studies . Brain Res 1974;72:79-97.Crossref 213. DeMontigny C, Aghajanian GK: Tricyclic antidepressants: Longterm treatment increases responsivity of rat forebrain neurons to serotonin . Science 1978;202:1303-1306.Crossref 214. Gallager DW, Bunney WE Jr: Failure of chronic lithium treatment to block tricyclic antidepressant-induced 5-HT supersensitivity . Naunyn Schmiedebergs Arch Pharmacol 1979;307:129-133.Crossref 215. Huang YH: Chronic desipramine treatment increases activity of noradrenergic postsynaptic cells . Life Sci 1979;25:709-716.Crossref 216. Rogawski MA, Aghajanian GK: Activation of lateral geniculate neurons by norepinephrine: Mediation by an α-adrenergic receptor . Brain Res 1980;182:345-359.Crossref 217. Menkes DB, Aghajanian GK, McCall RB: Chronic antidepressant treatment enhances α-adrenergic and serotonergic responses in the facial nucleus . Life Sci 1980;27:45-55.Crossref 218. Menkes DB, Aghajanian GK: Alpha-l-adrenoceptor-mediated responses in the lateral geniculate nucleus are enhanced by chronic antidepressant treatment . Eur J Pharmacol , to be published. 219. Wang RY, Aghajanian GK: Enhanced sensitivity of amygdaloid neurons to serotonin and norepinephrine after chronic antidepressant treatment . Commun Psychopharmacol 1980;4:83-90. 220. Horn AS: Structure activity relations for the inhibition of 5-HT uptake into rat hypothalamic homogenates by serotonin and tryptamine analogues . J Neurochem 1973;21:883-888.Crossref 221. Ross SB, Renyi AL: Inhibition of the uptake of tritiated 5-HT in brain tissue . Eur J Pharmacol 1969;4:270-277.Crossref 222. DeMontigny C: Electroconvulsive shock treatment increases responsiveness of forebrain neurons to serotonin: A microiontophoretic study in the rat . Neurosci Abstr 1980;6:453. 223. Olpe HR: Differential effects of chlorimipramine and clorgyline on the sensitivity of cortical neurons to serotonin: Effect of chronic treatment . Eur J Pharmacol 1981;69:375-377.Crossref 224. Blier P, de Montigny C: Effect of chronic tricyclic antidepressant treatment on the serotoninergic autoreceptor: A microiontophoretic study in the rat . Naunyn Schmiedebergs Arch Pharmacol 1980;314:123-128.Crossref 225. Aghajanian CK, Wang RY: Physiology and pharmacology of central serotonergic neurons , in Lipton MA, DeMascio A, Killam KF (eds): Psychopharmacology: A Generation of Progress . New York, Raven Press, 1978, pp 171-184. 226. Sheard MH, Zolovick A, Aghajanian GK: Raphe neurons: Effect of tricyclic antidepressant drugs . Brain Res 1972;43:690-694.Crossref 227. Chiodo LA, Antelman SA: Repeated tricyclics induced a progressive dopamine autoreceptor subsensitivity independent of daily drug treatment . Nature 1980;287:451-454.Crossref 228. Chiodo LA, Antelman SA: Electroconvulsive shock: Progressive dopamine auto-receptor subsensitivity independent of repeated treatment . Science 1980;210:799-801.Crossref 229. Olpe HR, Schellenberg A: Reduced sensitivity of neurons to noradrenaline after chronic treatment with antidepressant drugs . Eur J Pharmacol 1980;63:7-13.Crossref 230. Jones RSG: Long-term administration of atropine, imipramine, and viloxazine alters responsiveness of rat cortical neurons to acetylcholine . Can J Physiol 1980;58:531-535.Crossref 231. Siggins GR, Schultz JE: Chronic treatment with lithium or desipramine alters discharge frequency and norepinephrine responsiveness of cerebellar Purkinje cells . Proc Natl Acad Sci USA 1979;76:5987-5991.Crossref 232. Schultz JE, Siggins GR, Schocker FW, et al: Effects of prolonged treatment with lithium and tricyclic antidepressants on discharge frequency, norepinephrine responses and beta receptor binding in rat cerebellum: Electrophysiological and biochemical comparison . J Pharmacol Exp Ther 1981;216:28-38. 233. Modigh K: Electroconvulsive shock and postsynaptic catecholamine effects: Increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS . J Neural Transm 1975;36:19-32.Crossref 234. Maj J, Mogilnicka E, Klimek V: The effect of repeated administration of antidepressant drugs on the responsiveness of rats to catecholamine agonists . J Neural Transm 1979;44:221-235.Crossref 235. Maj J, Mogilnicka E, Kordecka A: Chronic treatment with antidepressant drugs: Potentiation of apomorphine-induced aggressive behaviour in rats . Neurosci Lett 1979;13:337-341.Crossref 236. Maj J, Mogilnicka E, Kordecka-Magiera A: Effects of chronic administration of antidepressant drugs on aggressive behavior induced by clonidine in mice . Pharmacol Biochem Behav 1979;13:153-154.Crossref 237. Anden N-E, Strombom U, Svensson TH: Dopamine and noradrenaline receptor stimulation: Reversal of reserpine-induced suppression of motor activity . Psychopharmacologia 1973;29:289-298.Crossref 238. Morpurgo C: Aggressive behavior induced by large doses of 2(2,6-dichlorphenyl-amino)-2-imidazoline hydrochloride (St 155) in mice . Eur J Pharmacol 1968;3:374-378.Crossref 239. Maj J, Mogilnicka E, Klimek V: Dopaminergic stimulation enhances the utilization of noradrenaline in the central nervous system . J Pharm Pharmacol 1977;29:569-570.Crossref 240. Mogilnicka E, Klimek V: Mianserin, danitracen and amitriptyline withdrawal increases the behavioural responses of rats to L-5-HTP . J Pharm Pharmacol 1979;31:704-705.Crossref 241. Friedman E, Dallob A: Enhanced serotonin receptor activity after chronic treatment with imipramine or amitriptyline . Commun Psychopharmacol 1979;3:89-92. 242. Jones RSG: Enhancement of 5-hydroxytryptamine-induced behavioral effects following chronic administration of antidepressant drugs . Psychopharmacology 1980;69:307-311.Crossref 243. Evans JPM, Grahame-Smith DG, Green AR, et al: Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs . Br J Pharmacol 1976;56:193-199.Crossref 244. Green AR, Heal DJ, Grahame-Smith DG: Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5hydroxytryptamine and dopamine . Psychopharmacology 1977;52:195-200.Crossref 245. Grahame-Smith DG, Green AR, Costain DW: Mechanism of the antidepressant action of electroconvulsive therapy . Lancet 1978;1:254-257.Crossref 246. Costain DW, Green AR, Grahame-Smith DG: Enhanced 5-hydroxytryptamine-mediated behavioural responses in rats following repeated electroconvulsive shock: Relevance to the mechanism of the antidepressive effect of electroconvulsive therapy . Psychopharmacology 1979;61:167-170.Crossref 247. Green AR, Deakin JFW: Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour . Nature 1980;285:232-233.Crossref 248. Fuxe K, Ogren S-O, Agnati L, et al: On the mechanism of action of the antidepressant drugs amitriptyline and nortriptyline: Evidence for 5-hydroxytryptamine receptor blocking activity . Neurosci Lett 1977;6:339-344.Crossref 249. Maj J, Lewandowska A, Rawlow A: Central antiserotonin action of amitriptyline . Pharmakopsychiatr Neuropsychopharmakol 1979;12:281-285.Crossref 250. Maj J, Sowinska H, Baran L, et al: The antiserotonin actions of mianserin . Psychopharmacology 1978;59:79-84.Crossref 251. Peet M, Coppen A: The pharmacokinetics of antidepressant drugs: Relevance to their therapeutic effect , in Paykel ES, Coppen A (eds): Psychopharmacology of Affective Disorders . New York, Oxford University Press Inc, 1979, pp 91-107. 252. Sachar EJ: Twenty-four hour cortisol patterns in depressed and manic patients . Prog Brain Res 1975;42:81-91. 253. Carrol BJ, Mendels J: Neuroendocrine regulation in depression , in Sachar E (ed): Hormones, Behavior and Psychopathology . New York, Raven Press, 1976, pp 192-224. 254. Sachar EJ, Hellman L, Roffwarg HP, et al: Disrupted 24-hour patterns of cortisol secretion in psychotic depression . Arch Gen Psychiatry 1973;28:19-24.Crossref 255. Carroll BJ, Curtis GC, Mendels J: Neuroendocrine regulation in depression: I. Limbic system-adrenocortical dysfunction . Arch Gen Psychiatry 1976;33:1039-1044.Crossref 256. Carroll BJ, Curtis GC, Mendels J: Neuroendocrine regulation in depression: II. Discrimination of depressed from nondepressed patients . Arch Gen Psychiatry 1976;33:1051-1058.Crossref 257. Checkley SA: Corticosteroid and growth hormone responses to methylamphetamine in depressive illness . Psychol Med 1978;8:1-9.Crossref 258. Sachar EJ, Asnis G, Nathan S, et al: Dextroamphetamine and cortisol in depression: Morning plasma cortisol levels suppressed . Arch Gen Psychiatry 1980;37:755-757.Crossref 259. Brown WA, Shuey I: Response to dexamethasone and subtype of depression . Arch Gen Psychiatry 1980;37:747-751.Crossref 260. Schlesser MA, Winokur G, Sherman BM: Hypothalamic-pituitaryadrenal axis activity in depressive illness: Its relationship to classification . Arch Gen Psychiatry 1980;37:737-743.Crossref 261. Greden JF, Tarika JS, Devigne J-P, et al: Dexamethasone test predicts treatment response. Read before the 133rd annual meeting of the American Psychiatric Association, San Francisco, May 1980. 262. Goldberg IK: Dexamethasone suppression test as indicator of safe withdrawal of antidepressant therapy . Lancet 1980;1:376.Crossref 263. Mueller PS, Heninger GR, McDonald RK: Insulin tolerance test in depression . Arch Gen Psychiatry 1969;21:587-594.Crossref 264. Carroll BJ: Studies with hypothalamic-pituitary-adrenal stimulation tests in depression , in Davies B, Carroll BJ, Mowbray RM (eds): Depressive Rlness: Some Research Studies . Springfield, Ill, Charles C Thomas Publisher, 1972, pp 149-201. 265. Sachar EJ, Finkelstein J, Hellman L: Growth hormone responses in depressive illness: I. Response to insulin tolerance test . Arch Gen Psychiatry 1971;25:263-269.Crossref 266. Gruen PH, Sachar EJ, Altman N, et al: Growth hormone responses to hypoglycemia in postmenopausal depressed women . Arch Gen Psychiatry 1975;32:31-33.Crossref 267. Endo M, Endo J, Nishikubo M, et al: Endocrine studies in depression , in Hatotani N (ed): Psychoneuroendocrinology . New York, S Karger AG, 1974, pp 22-31. 268. Czernik A, Kleesick K: Insulin-sensitivity and pituitary hormone secretion in the course of depressive syndromes , in Radouco-Thomas C, Garcia F (eds): Progress in Neuro-Psychopharmacology . New York, Pergamon Press, 1980, vol 12, suppl 1, p 120. 269. Blackard WJ, Heidingsfelder A: Adrenergic receptor control mechanism for growth hormone secretion . J Clin Invest 1968;47:1407-1414.Crossref 270. Bivens CH, Lebovits HE, Feldman JM: Inhibition of hypoglycemia induced growth hormone secretion by the serotonin antagonists cyproheptadine and methysergide . N Engl J Med 1973;289:236-239.Crossref 271. Langer G, Heinze G, Reim B, et al: Reduced growth hormone responses to amphetamine in 'endogenous' depressive patients: Studies in normal, 'reactive' and 'endogenous' depressive, schizophrenic, and chronic alcoholic subjects . Arch Gen Psychiatry 1970;33:1471-1475.Crossref 272. Matussek N, Ackenheil M, Hippius H, et al: Effect of clonidine on growth hormone release in psychiatric patients and controls . Psychiatr Res 1980;2:25-36.Crossref 273. Checkley SA: Corticosteroid and growth hormone responses to methylamphetamine in depressive illness . Psychol Med 1979;9:107-115.Crossref 274. Checkley SA, Slade AP, Shur E: Growth hormone and other responses to clonidine in patients with endogenous depression . Br J Psychiatry 1981;138:51-55.Crossref 275. Checkley SA, Slade AP, Shur E, et al: A pilot study of the mechanism of action of desipramine . Br J Psychiatry 1981;138:248-251.Crossref 276. Loosen PT, Prange AJ Jr: Thyrotropin releasing hormone (TRH): A useful tool for psychoneuroendocrine investigation . Psychoneuroendocrinology 1980;5:63-80.Crossref 277. Gregoire F, Brauman H, de Buck R, et al: Hormone release in depressed patients before and after recovery . Psychoneuroendocrinology 1977;2:303-312.Crossref 278. Kirkegaard C, Bjorum N, Cohn D, et al: Studies on the influence of biogenic amines and psychoactive drugs on the prognostic value of the TRH stimulation test in endogenous depressoin . Psychoneuroendocrinology 1977;2:131-136.Crossref 279. Kirkegaard C, Smith E: Continuation therapy in endogenous depression controlled by changes in the TRH stimulation test . Psychol Med 1978;8:501-503.Crossref 280. Kirkegaard C, Norlem N, Lauridsen UB, et al: Prognostic value of thyrotropin-releasing hormone stimulation test in endogenous depression . Acta Psychiatr Scand 1975;52:170-177.Crossref 281. Takahashi S, Kondo H, Yoshimura M, et al: Growth hormone responses to administration of L-5-hydroxytryptophan (L-5-HTP) in manicdepressive psychoses . Folia Psychiatr Neurol Jpn 1973;27:197-206. 282. Kato Y, Nakai Y, Imura H, et al: Effects of 5-hydroxytryptophan on plasma prolactin levels in man . J Clin Endocrinol Metab 1974;38:695-697.Crossref 283. Sachar EJ, Nathan RS, Asnis G, et al: Neuroendocrine studies of major depressive disorder . Acta Psychiatr Scand 1980;61( (suppl 260) ):201-210. 284. Cavagnini F, Raggi V, Micossi P, et al: Effect of an antiserotonergic drug metergoline on the ACTH and cortisol response to insulin hypoglycemia and lysine vasopressin in man . J Clin Endocrinol Metab 1976;43:306-312.Crossref 285. Krulich L: The role of central monoamines in stress-related changes of the secretion of prolactin and TSH . Psychopharmacol Bull 1976;12( (Oct) ):22-24. 286. Coppen A, Rao Rama VA, Bishop M, et al: Neuroendocrine studies in affective disorders: I. Plasma prolactin response to thyrotropin-releasing hormone in affective disorders: Effect of ECT . J Affect Disord 1980;2:311-315.Crossref 287. Prange AJ, McCurdy RL, Cochrane CM: The systolic blood pressure response of depressed patients to infused norepinephrine . Psychiatr Res 1967;5:1-13.Crossref 288. Pickar D, Cohen RM, Murphy DL, et al: Tyramine infusions in bipolar illness: Behavioral effects and longitudinal changes in pressor sensitivity . Am J Psychiatry 1979;136:1460-1464. 289. Chose K, Coppen'A, Turner P: Autonomic actions and interactions of mianserin hydrochloride (Org. GB 94) and amitriptyline in patients with depressive illness . Psychopharmacology 1976;49:201-204.Crossref 290. Coppen A, Ghose K: Peripheral α-adrenoreceptor and central dopamine receptor activity in depressive patients . Psychopharmacology 1978;59:171-177.Crossref 291. Fann WE, Davis JM, Janowsky DS, et al: Effect of antidepressant and antimanic drugs on amine uptake in man . J Nerv Ment Dis 1974;158:361-368.Crossref 292. Freyschuss U, Sjoqvist F, Tuck D: Tyramine pressor effects in man before and during treatment with nortriptyline or ECT: Correlation between plasma level and effect of nortriptyline . Pharmacol Clin 1970;2:72-78.Crossref 293. Bevan P, Bradshaw CM, Szabadi E: The pharmacology of adrenergic neuronal responses in the cerebral cortex: Evidence for excitatory α- and inhibitory β-receptors . Br J Pharmacol 1977;59:635-641.Crossref 294. Waterhouse BD, Moises HC, Woodward DJ: Alpha, beta pharmacological characterization of noradrenergic modulatory actions in rat somatosensory cortex . Neurosci Abstr 1979;5:356. 295. Rees L, Butler PWP, Gosling C, et al: Adrenergic blockade and the corticosteroid and growth hormone responses to methylamphetamine . Nature 1970;288:565-566.Crossref 296. Imura H, Kato Y, Ikeda M, et al: Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin and blood free fatty acid levels in man . J Clin Invest 1971;50:1069-1079.Crossref 297. Hoffman BB, Lefkowitz RJ: Radioligand binding studies of adrenergic receptors . Ann Rev Pharmacol Toxicol 1980;20:581-608.Crossref 298. Maggi A, U'Prichard DC, Enna SJ: β-Adrenergic regulation of α-adrenergic receptors in the central nervous system . Science 1980;207:645-647.Crossref 299. U'Prichard DC, Kvetnansky R: Central and peripheral adrenergic receptors in acute and repeated immobilization stress , in Kopin IF, Usdin E, Kvetnansky R (eds): Second International Symposium on Catecholamines and Stress . New York, Elsevier North Holland Inc, to be published. 300. Pujol JF, Keane P, McRae A, et al: Biochemical evidence for serotonergic control of the locus coeruleus , in Garattini S, Pujol JF, Samanin R (eds): Interactions Between Putative Neurotransmitters in the Brain . New York, Raven Press, 1978, pp 401-410. 301. Roizen MF, Jacobowitz DM: Studies on the origin of innervation of the noradrenergic area bordering on the nucleus raphe dorsalis . Brain Res 1976;101:561-568.Crossref 302. Fuxe K: Evidence for the existence of monoamine nerve terminals in the central nervous system: IV. Distribution of monoamine nerve terminals in the central nervous system . Acta Physiol Scand 1965;64( (suppl 247) ):37-85.Crossref 303. Hokfelt T, Fuxe K, Goldstein M, et al: Immunohistochemical evidence for the existence of adrenaline neurons in the rat brain . Brain Res 1974;66:235-251.Crossref 304. Swanson LW, Hartman BK: The central adrenergic system: An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-β-hydroxylase as a marker . J Comp Neurol 1975;163:467-506.Crossref 305. Hokfelt T, Johansson O, Fuxe K, et al: Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain: I. Tyrosine hydroxylase in the mesencephalon and diencephalon . Med Biol 1976;54:427-453. 306. Descarries L, Leger L: Serotonergic nerve terminals in the locus coeruleus of the adult rat , in Garattini S, Pujol JF, Samanin R (eds): Interactions Between Putative Neurotransmitters in the Brain . New York, Raven Press, 1978, pp 355-368. 307. Baraban JM, Aghajanian GK: EM autoradiographic studies of adrenergic input to the dorsal raphe . Neurosci Abstr 1979;5:329. 308. Svensson TH, Bunney BS, Aghajanian GK: Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine . Brain Res 1975;92:291-306.Crossref 309. Gallager DW, Aghajanian GK: Effect of antipsychotic drugs on the firing of dorsal raphe cells: I. The role of adrenergic system . Eur J Pharmacol 1976;39:341-355.Crossref 310. Baraban JM, Wang RY, Aghajanian GK: Reserpine suppression of dorsal raphe neuronal firing: Mediation by adrenrgic system . Eur J Pharmacol 1978;52:27-36.Crossref 311. Baraban JM, Aghajanian GK: Suppression of firing activity of 5-HT neurons in the dorsal raphe by α-adrenoceptor antagonists . Neuropharmacology 1980;19:355-363.Crossref 312. Zis AP, Goodwin FK: Novel antidepressants and the biogenic amine hypothesis of depression: The case for iprindole and mianserin . Arch Gen Psychiatry 1979;36:1097-1107.Crossref 313. Brunel S, de Montigny C: Diurnal variation in the responsiveness of hippocampal pyramidal neurons to serotonin . Neurosci Abstr 1980;6:833. 314. Wehr TA, Muscettola G, Goodwin FK: Urinary 3-methoxy-4-hydroxyphenylglycol circadian rhythm: Early timing (phase-advance) in manicdepressives compared with normal subjects . Arch Gen Psychiatry 1980;37:257-263.Crossref 315. Pflug B, Erikson R, Johnsson A: Depression and daily temperature: A long-term study . Acta Psychiatr Scand 1978;54:254-266.Crossref 316. Wehr TA, Wirz-Justice A, Goodwin FK, et al: Phase advance of the sleep-wake cycle as an antidepressant . Science 1979;206:710-713.Crossref 317. Foster FG, Kupfer DJ: Psychomotor activity as a correlate of depression and sleep in acutely disturbed psychiatric patients . Am J Psychiatry 1975;132:928-931. 318. Halbreich U, Grunhaus L, Ben-David M: Twenty-four-hour rhythm of prolactin in depressive patients . Arch Gen Psychiatry 1979;36:1183-1186.Crossref 319. Nelson JC, Charney DS: The symptoms of major depressive illness . Am J Psychiatry 1981;138:1-13.Crossref 320. Leckman JF, Maas JW, Redmond DE, et al: Effects of oral clonidine on plasma 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) in man: preliminary report . Life Sci 1980;26:2179-2185.Crossref 321. Paul SM, Crews FM: Rapid desensitization of cerebral cortical β-adrenergic receptors induced by desmethylimipramine and phenoxybenzamine . Eur J Pharmacol 1980;62:349-350.Crossref 322. De Montigny C, Grunberg F, Mayer A, et al: Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders . Br J Psychiatry 1981;138:252-256.Crossref 323. Prange AJ, Wilson JC, Wabon AM, et al: Enhancement of imipramine antidepressant activity by thyroid hormone . Am J Psychiatry 1969;126:457-469. 324. Prange AJ, Wilson IC, Knox A, et al: Enhancement of imipramine by thyroid stimulating hormone: Clinical and theoretical implications . Am J Psychiatry 1970;127:191-199. 325. Earle BV: Thyroid hormone and tricyclic antidepressants in resistant depressions . Am J Psychiatry 1970;126:1667-1669. 326. Wheatley D: Potentiation of amitriptyline by thyroid hormone . Arch Gen Psychiatry 1972;26:229-233.Crossref 327. Coppen A, Whybrow PC, Noguera R, et al: The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine . Arch Gen Psychiatry 1972;26:234-241.Crossref 328. Feighner JP, King LJ, Schuckit MA, et al: Hormonal potentiation of imipramine and ECT in primary depression . Am J Psychiatry 1972;128:1230-1238. 329. Prange AJ Jr, in discussion, Feighner JP, King LJ, Schuckit MA, et al: Hormonal potentiation of imipramine and ECT in primary depression . Am J Psychiatry 1972;128:1230-1238. 330. Ogura C, Okuma T, Uchida Y, et al: Combined thyroid (triiodothyronine)-tricyclic antidepressant treatment in depressive states . Folia Psychiatr Neurol Jpn 1974;28:179-186. 331. Karlberg BE, Kjellman BF, Kagedal B: Treatment of endogenous depression with oral thyrotropin releasing hormone and amitriptyline . Acta Psychiatr Scand 1978;58:389-400.Crossref 332. Grob G, Brodde OE, Schumann HJ: Regulation of α1-adrenoceptors in the cerebral cortex of the rat by thyroid hormones . Naunyn Schmiedebergs Arch Pharmacol 1981;316:45-50.Crossref 333. Strombom U, Svensson TH, Jackson DM, et al: Hyperthroidism: Specifically increased response to central NA-(α-) receptor stimulation and generally increased monoamine turnover in brain . J Neural Transm 1977;41:73-92.Crossref

Journal

Archives of General Psychiatry – American Medical Association

Published: Oct 1, 1981

There are no references for this article.